US20100233301A1 - Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same - Google Patents

Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same Download PDF

Info

Publication number
US20100233301A1
US20100233301A1 US12/713,959 US71395910A US2010233301A1 US 20100233301 A1 US20100233301 A1 US 20100233301A1 US 71395910 A US71395910 A US 71395910A US 2010233301 A1 US2010233301 A1 US 2010233301A1
Authority
US
United States
Prior art keywords
skin
topical composition
fermented
composition
yin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/713,959
Inventor
Jing Cheng
Chia-Wen Chen
Sleven Francis Schnittger
Ming Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/713,959 priority Critical patent/US20100233301A1/en
Publication of US20100233301A1 publication Critical patent/US20100233301A1/en
Priority to US13/270,529 priority patent/US8580319B2/en
Priority to US13/270,558 priority patent/US20120270291A1/en
Priority to US14/043,021 priority patent/US9327004B2/en
Priority to US14/043,035 priority patent/US9333231B2/en
Priority to US14/043,014 priority patent/US9233134B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • A61K36/068Cordyceps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/10Bryophyta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235Foeniculum (fennel)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/69Polygalaceae (Milkwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998Hordeum (barley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Definitions

  • the present invention relates to topical compositions for improving the appearance and skin condition of a user, while such topical compositions contain fermented extracts of Traditional Chinese Medicinal (TCM) ingredients with reduced color and odor.
  • TCM Traditional Chinese Medicinal
  • the present invention also relates to computer-based system and method for determining the skin composition of a specific user and selecting a suitable topical composition for such user based on his or her skin composition according to TCM principles.
  • TCM Traditional Chinese Medicine
  • TCM believes that an internal physiological balance has to be maintained for a person to be healthy, and all diseases are caused by one or more types of imbalances, and each type of imbalances manifests through an identifiable pattern of symptom and requires a particular set of treatments for correction.
  • a TCM practitioner typically uses a compound prescription containing a blend of multiple herbal ingredients to treat various symptoms of a disease after careful examination of an individual patient, and such prescription is specifically designed for the patient to re-establish the internal physiological balance of such patient.
  • the TCM practice takes an individualized treatment approach, instead of a “one-size-fits-all” treatment approach.
  • TCM ingredients into cosmetic or skin care products
  • a problem commonly encountered when formulating TCM ingredients into cosmetic or skin care products is the distinctive color and undesirable odor associated with many TCM ingredients, which makes it difficult to form aesthically and olfactorily acceptable cosmetic or skin care compositions containing such TCM ingredients. It would also be desirable to process TCM ingredients by reducing the color and odor so that they can be readily formulated into aesthically and olfactorily acceptable cosmetic or skin care compositions.
  • the present invention provides topical compositions, each of which contains a unique blend of TCM ingredients specifically designed to improve the appearance and skin conditions of a particular sub-population of users characterized by a specific skin composition, according to the TCM principles.
  • one aspect of the present invention relates to a topical composition containing fermented extracts of Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel, which can be applied to the skin of a user with a balanced skin composition to improve the appearance and skin conditions of said user.
  • Another aspect of the present invention relates to a topical composition containing fermented extracts of Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower, which can be applied to the skin of a user with a Yang-dominant or balanced-to-Yang skin composition to nourish Yin and store the Yin-Yang balance in the skin.
  • a further aspect of the present invention relates to a topical composition containing fermented extracts of Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed, which can be applied to the skin of a user with a Yin-dominant or balanced-to-Yin skin composition to nourish Yin and store the Yin-Yang balance in the skin.
  • the present invention also provides a method for preparing a topical composition by first fermenting a blend of extracts from one or more TCM ingredients known to have undesirable odor and/or color in the presence of an aerobically metabolizing microorganism under suitable aerobic conditions for a period of time sufficient to reduce or eliminate the undesirable odor and/or color while preserving desirable biological activities of said TCM ingredients, and then formulating the fermented blend of TCM extracts into a cosmetically or pharmaceutically acceptable carrier to form said topical composition.
  • the present invention provides a method for selecting a topical composition for a user to improve the appearance or skin condition of said user based on his or her skin composition, comprising: (a) collecting biological data from the user; (b) categorizing the skin composition of the user based on the collected biological data, wherein said categorization is indicative of the Yin-Yang balance of the skin or the lack thereof; and (c) selecting a topical composition for the user, wherein said topical composition contains a blend of fermented Chinese herbal extracts for maintaining or restoring the Yin-Yang balance of the skin.
  • the skin composition of the user is categorized by using a statistical model that weights the biological data according to TCM principles.
  • the present invention provides several topical compositions, each of which contains a unique combination of fermented extracts of TCM ingredients for targeting a sub-population of users with a specific skin composition according to the TCM principles.
  • health is represented as a balance of Yin and Yang, which are opposing forces interconnected and interdependent in the natural world, giving rise to each other in turn. These two forces represent the bipolar manifestation of all things in nature, and because of this, one must be present to allow the other to exist.
  • a constantly changing balance between Yin and Yang should be maintained within the body of a person. When one force is regularly dominating over the other, the health of the patient can become compromised, resulting in illness and disease. Therefore, when diagnosing a patient, TCM practitioners usually try to determine the exact nature of the Yin/Yang imbalance, and then correct it through the use of acupuncture, herbal remedies, exercise, diet and lifestyle. Once the balance is restored in the body, so is health.
  • the topical compositions provided by the present invention are specifically designed for different sub-population of users with different skin compositions, which can be categorized according to the Yin and Yang balance/imbalance of the skin.
  • the skin compositions can be divided into three major categories: the Yin-Yang balanced skin composition (hereinafter referred to as “balanced skin composition”), the Yang-dominant skin composition, and the Yin-dominant skin composition. Additional categories can also be included to further quantify the degree of imbalance.
  • the skin composition categorization may further include a balance-to-Yang skin composition and a balance-to-Yin skin composition, which are relatively balanced skin compositions with slight Yang or Yin symptoms.
  • the specific skin composition of a patient can be determined by observing the skin condition, tongue color and tongue fur color of the patient (which are two important factors to be considered by TCM practitioners for diagnosis), as well as by gathering certain information from the patient regarding the person's age, bodily sensation, sleep pattern, and energy level.
  • the balanced skin composition is typically characterized by smooth, radiant, soft and delicate skin with good elasticity and even skin tone, and patients with the balanced skin composition usually also have lips and tongue of light red color with thin, pale white tongue fur color.
  • the Yang-dominant skin composition is typically characterized by reddish cheek and red skin tone, oily skin surface, and tendency to develop allergy, acne, pigmentation, and pre-mature wrinkles.
  • Patients with the Yang-dominant skin composition may also have lips and tongue of bright red color with yellow tongue fur color, and they typically prefer cold drinks, become thirsty very easily, have bitter tastes in the mouth, often sweat when sleeping at night, easily irascible, and often suffer from internal heat.
  • the Yin-dominant skin composition is typically characterized by pale skin tone, dry and easily desquamated skin with low water absorption and water retention capacity, and tendency to develop pigmentation and pre-mature wrinkles.
  • Patients with the Yin-dominant skin composition may have pale or blue lips, light red or pale tongue color with white tongue fur color, and they typically prefer hot drinks, have relatively cold hands and feet, are sensitive to temperature decrease, and often feel tired or sleepy.
  • Patients with balanced-to-Yang or balanced-to-Yin skin composition may exhibit similar symptoms as those with Yang-dominant or Yin-dominant skin composition but to a lesser degree.
  • the present invention provides a method for selecting cosmetic or skin care products for users based on their specific skin compositions, by first collecting biological data (e.g., age, bodily sensation, sleep pattern, energy level, tongue color, tongue fur color, and skin condition of the user), then determining the skin composition of the user based on the collected biological data, and finally selecting a suitable cosmetic or skin care product for the user corresponding to his or her skin composition.
  • biological data e.g., age, bodily sensation, sleep pattern, energy level, tongue color, tongue fur color, and skin condition of the user
  • the biological data was collected by a preliminary facial examination of the user as well as requesting the user to fill out a questionnaire, and the data so collected is then processed by a computer-based system programmed with a statistical model for specifically for determining the skin compositions of a user by weighing the collected biological data according to TCM principles.
  • the TCM practice adopts a compound or combinational approach in its herbal therapy, i.e., by using a blend of different herbal ingredients to target the root cause as well as different symptoms of the disease.
  • a typical TCM formula contains four major ingredients, each playing its unique role while working together synergistically to achieve the optimal treatment results. The four major ingredients have been described in ancient texts as “emperor” or “king,” “minister,” “assistant” and “servant.” This TCM philosophy models these four major ingredients components in a compound formula after a court of an emperor.
  • the emperor or king ingredient serves as the principle in attacking the root cause of the disease; the minister ingredient acts to assist and augment the emperor or king ingredient; the assistant ingredient also assists the emperor or king ingredient, but it focuses on counter-reacting any possible side-effects of the emperor or king ingredient; and the servants ingredient acts to deliver the medicine where it should go.
  • a single ingredient may perform double or triple duties in a single TCM herbal formula, e.g., both as the king and the minister, or as the king, the minister and the assistant, or the like.
  • the TCM herbal formula may have only 2 or 3 ingredients in total.
  • a blend of fermented plant extracts containing at least four, and preferably seven, ingredients is provided for users with a balanced skin composition to maintain and strengthen the balance between Yin and Yang in the patient's skin, improve the immune system and the skin barrier function of the patient, revitalize the skin, and enhance self-repair function of the skin.
  • Such a blend contains fermented extracts from Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel.
  • the Cordyceps sinensis mycelia extract functions as the emperor or king ingredient in this blend; the Ginkgo biloba leaf extract functions as the minister ingredient; the Polygonum cuspidatum rhizome extract functions as the assistant ingredient; and the Citrus reticulata peel extract functions as the servant ingredient.
  • this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Poria cocos sclerotium, Panax ginseng root, and Perilla frutescens fruit, and most preferably, it comprises all three additional minister ingredients.
  • the fermented extract of Cordyceps sinensis mycelia is preferably present in this blend at an amount ranging from about 10% to about 40%, more preferably from about 15% to about 35%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Ginkgo biloba leaf is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Polygonum cuspidatum rhizome is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Citrus reticulata peel is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Poria cocos sclerotium is preferably at an amount ranging from about 10% to about 40%, more preferably from about 15% to about 35%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Panax ginseng root is preferably at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 3% to about 5%, by total weight of the blend.
  • the Perilla frutescens fruit is preferably at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the present invention provides a blend of fermented plant extracts containing at least four, and preferably seven, ingredients to nourish the Yin energy in the skin, balance/neutralize the excess Yang energy, promote metabolism in the skin, facilitate circulation of bodily fluid as well as transportation of any turbid Qi (which is believed to be the cause of various diseases in TCM theories), regulate the immune system, improve the skin barrier function, and enhance the self-repair function of the skin.
  • a blend contains fermented extracts from Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower.
  • the Ganoderma lucidum fruiting body extract functions as the emperor or king ingredient in this blend; the Selaginella tamariscina plant functions as the minister ingredient; the Ginkgo biloba leaf extract functions as the assistant ingredient; and the Calendula officinalis flower extract functions as the servant ingredient.
  • this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Centella asiatica plant, Scutellaria baicalensis root, and Polygonum cuspidatum rhizome, and most preferably, it comprises all three additional minister ingredients.
  • the fermented extract of Ganoderma lucidum fruiting body is preferably present in this blend at an amount ranging from about 10% to about 45%, more preferably from about 15% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Selaginella tamariscina plant is preferably present in this blend at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Ginkgo biloba leaf is preferably present in this blend at an amount ranging from about 0.1% to about 20%, more preferably from about 1% to about 15%, and most preferably from about 3% to about 10%, by total weight of the blend.
  • the fermented extract of Calendula officinalis flower is preferably present in this blend at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Centella asiatica plant is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the fermented extract of Scutellaria baicalensis root is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • the Polygonum cuspidatum rhizome is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • This blend of fermented plant extracts is used to balance both the Yang-dominant skin composition and the balanced-to-Yang skin composition, but at different concentrations.
  • the concentrations of fermented plant extracts in products designated for the balanced-to-Yang skin composition are preferably from 25% to 75%, more preferably from about 40% to about 60%, of those in products designated for the Yang-dominant skin composition.
  • the present invention provides a blend of fermented plant extracts containing at least four, and preferably seven, ingredients to nourish the Yang energy in the skin, balance/neutralize the excess Yin energy, strengthen the body fluid circulation, improve the immune system, enhance the skin barrier function, and enhance the self-repair function of the skin.
  • a blend contains fermented extracts from Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed.
  • the Rhodiola rosea rhizome extract functions as the emperor or king ingredient in this blend; the Perilla frutescens fruit functions as the minister ingredient; the Phellodendron amurense bark extract functions as the assistant ingredient; and the Foeniculum vulgare seed extract functions as the servant ingredient.
  • this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Santalum album stem, Hordeum distichon seed, and Citrus reticulata peel, and most preferably, it comprises all three additional minister ingredients.
  • the fermented extract of Rhodiola rosea rhizome is preferably present in this blend at an amount ranging from about 10% to about 50%, more preferably from about 15% to about 45%, and most preferably from about 25% to about 30%, by total weight of the blend.
  • the fermented extract of Perilla frutescens fruit is preferably present in this blend at an amount ranging from about 0.5% to about 30%, more preferably from about 1% to about 20%, and most preferably from about 5% to about 15%, by total weight of the blend.
  • the fermented extract of Phellodendron amurense bark is preferably present in this blend at an amount ranging from about 0.5% to about 30%, more preferably from about 1% to about 20%, and most preferably from about 5% to about 15%, by total weight of the blend.
  • the fermented extract of Foeniculum vulgare seed is preferably present in this blend at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 2% to about 5%, by total weight of the blend.
  • the fermented extract of Santalum album stem is preferably at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 2% to about 5%, by total weight of the blend.
  • the fermented extract of Hordeum distichon seed is preferably at an amount ranging from about 10% to about 50%, more preferably from about 15% to about 45%, and most preferably from about 25% to about 30%, by total weight of the blend.
  • the Citrus reticulata peel is preferably at an amount ranging from about 5% to about 40%, more preferably from about 10% to about 30%, and most preferably from about 15% to about 20%, by total weight of the blend.
  • This blend of fermented plant extracts is used to balance both the Yin-dominant skin composition and the balanced-to-Yin skin composition, but at different concentrations.
  • the concentrations of fermented plant extracts in products designated for the balanced-to-Yin skin composition are preferably from 25% to 75%, more preferably from about 40% to about 60%, of those in products designated for the Yin-dominant skin composition.
  • the present invention further provides a blend of fermented plant extracts for treating dark circles, puffiness, and wrinkles around the periorbital areas.
  • dark circles are caused by stasis of Qi and body fluid
  • puffiness around the eye area is caused by dampness and stasis of body fluid. Therefore, the present invention provides a blend of fermented plant extracts containing four ingredients for complementing Qi, improving the circulation of body fluid, removing dampness, tightening the skin, and prevent pre-mature skin aging.
  • Such a blend contains fermented extracts from Ligusticum chuangxiong root, Paeonia lactiflora root, Rehmannia glutinosa root, and Zizyphus jujube fruit.
  • the Ligusticum chuangxiong root extract functions as the emperor or king ingredient in this blend; the Paeonia lactiflora root functions as the minister ingredient; the Rehmannia glutinosa root extract functions as the assistant ingredient; and the Zizyphus jujube fruit extract functions as the servant ingredient.
  • the fermented extract of Ligusticum chuangxiong root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Paeonia lactiflora root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Rehmannia glutinosa root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • the fermented extract of Zizyphus jujube fruit is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • plant extracts can further include other plant extracts of known skin care benefit but are not specifically mentioned herein.
  • plant extracts may include, but are not limited to, those obtained from roots, leaves, flowers, stalks or other parts of plants such as Simmondsia Chinensis, Camellia Sinensis, Coffee Arabica, Betula Alba, Zea Mays, Siegesbeckia Orientalis, Helianthus Annus, Hordeum Vulgare, Cucumis Sativus, Carthamus Tinctorius, Mangifera Indicia, Garcinia Indica, Anthemus Nobilis, Arabidopsis Thaliana, Myrtus Communis, Apium Graveolens (Celery), Arabidopsis Thaliana, Padina Pavonica, Beta Vulgaris, Betula Alba, Butyrosperum Parkii, Garcinia Mangostana, Racemusus, Platycodon, Emblica Officinalis, Criste Marine, Lavande Papillon, Polygonum
  • extracts from certain fungi with known medicinal benefits can be included in the blends of plant extracts of the present invention.
  • fungi from the genus Trametes are known for their medicinal properties. Sophisticated outdoorsmen will sometimes chew a piece of fungi picked from Trametes Versicolor (also referred to as Turkey Tail) like gum when they are hiking in the woods. It has been discovered by the inventors that in addition to their known medicinal properties, Trametes extracts also have beneficial properties when applied to the skin. Specifically, Trametes extracts contain certain chemical components that are particularly effective in whitening or brightening the skin.
  • Extracts from the Trametes genus are also excellent moisturizers, and some species may also be useful in absorbing excess sebum in oily skinned individuals.
  • Various plants or raw plant materials as described hereinabove are first cut and cleaned and then subjected to a low temperature water extraction process, in which the plant materials are immersed in a solvent system consisting essentially of deionized water at a temperature ranging from about 75° C. to about 95° C. (preferably from about 80° C. to about 90° C.) and a pressure ranging from about 0.03 to about 0.05 mpa for a duration of about 8 to 10 hours.
  • the extraction solution is then concentrated at a temperature ranging from about 50° C. to about 65° C. (preferably from about 55° C.
  • the concentrated extract solution is then spray dried at a temperature ranging from about 100° C. to about 150° C., preferably 120° C. to about 140° C., to form fine powders ready for packaging and shipping.
  • the blends of plant extracts in the above-described fine powder form can be directly formulated into topical or cosmetic compositions.
  • topical or cosmetic compositions are typically characterized by a distinctive bitter odor and a brownish dark color commonly associated with TCM extracts and may not be considered aesthically and olfactorily acceptable by most users of cosmetic or skin care products.
  • the present invention employs a unique fermentation process to further treat the blends of plant extracts as described hereinabove.
  • the fermentation process of the present invention comprises incubating a blend of plant extracts in the presence of yeast, fungi, or other suitable aerobically metabolizing microorganisms, under suitable aerobic conditions, for a period of time sufficient to reduce or eliminate the undesirable odor and/or color of the plant extracts while preserving the desirable biological activities of the TCM ingredients.
  • the microorganism used for fermenting the plant extracts is a fungus from the genus Trametes , and more preferably from the species Trametes Versicolor.
  • the fermentation process can take either one of two approaches.
  • the first approach is a process in which the microorganism is fermented not only in the presence of the plant extracts but also with traditional culturing nutrients. During such incubation, the yeast or other microorganisms can multiply significantly in number.
  • the second, and preferred, approach is to ferment the yeast or other microorganisms in an aqueous environment, in the presence of only the plant extracts and in substantial absence of any additional nutrients, or in a low nutrient media, so that during the fermentation process, the yeast or other microorganisms only engage in catabolic processing of the plant extracts.
  • the incubation is monitored periodically for signs of the plateauing of biological activity, for example, a leveling off of pH, and then the system temperature is raised to between about 30-50° C., preferable about 40-45° C., for at least about 24 hours. In one embodiment, the temperature is then briefly raised to 90-95° C. for a period of about 5-10 minutes, which ruptures the yeast, releasing the cell contents. Alternately, the cells can be disrupted by sonication. The entire system is then cooled to room temperature, and filtered with progressively decreasing pore size to remove yeast debris, leaving a fermented extract that has significantly reduced odor and/or color in comparison with the unprocessed extract.
  • the amount of plant extracts used is also not critical; however, if it is desired to prevent proliferation of the yeast or other microorganisms, the amount should be controlled so as not to provide enough nutrients so to allow multiplication.
  • the amount of plant extracts used in the incubation medium of the present invention ranges from about 0.01 to about 10%, preferably from about 0.01 to about 5%, by total weight of the incubation medium, the concentration depending on the types of plant extracts used as well as on the solubility thereof.
  • the incubation medium contains simply water in addition to the plant extracts.
  • the water used is a structured water, i.e., I water, S water, or a combination of the two, as described, for example, in RO 88053 [S-type water], and RO 88054 (1-type water], and U.S. Pat. Nos. 5,846,397 and 6,139,855, the contents of which are incorporated herein by reference.
  • structured water in one or both of these phases of the fermentation process can further enhance the desired biological activities of the plant extracts.
  • the incubation medium is generally not supplied with any other nutrients besides the plant extracts, so that the sole source of substrate for the microorganisms' biochemical activity is the plant extracts provided.
  • the fermentation process can be performed in the presence of a nutrient medium appropriate for the growth of the microorganisms.
  • the fermentation process as described hereinabove not only functions to reduce or eliminate the undesirable odor and color typically associated with TCM ingredients, but is also capable of enhancing or boosting the desired biological activities of the TCM ingredients.
  • desired biological activities include, but are not limited to: ATP-elevating activities, anti-inflammation activities, anti-irritation activities, immune modulating activities, blood circulation-enhancing activities, anti-oxidant activities, photoprotective activities, anti-histamine activities, skin-whitening activities, anti-chemotactic activities, collagen synthesis-enhancing activities, fibronectin synthesis-enhancing activities, anti-glycation activities, anti-phospholipase A2 (PLA2) activities, phosphodiesterase (PDE)-inhibiting activities, superoxide dismutase (SOD)-like activities, DNA synthesis-enhancing activities, protein synthesis-enhancing activities, DNA-repairing activities, skin barrier-repairing activities, anti-glycosaminoglycanase activities, anti-elastase activities, catalase-like activities,
  • the fermented blends of plant extracts as described hereinabove can be used for formulating various cosmetic and skin care compositions of various forms, such as anhydrous or aqueous gels, solutions or serums, emulsions (such as water-in-oil, oil-in-water, water-in-silicone, or silicone-in-water emulsions).
  • Suggested amount of the fermented plant extracts as used in such compositions may range from about 0.001% to about 75%, preferably from about 0.05% to about 70%, more preferably from about 0.1% to about 65%.
  • the composition generally comprises from about 0.1-95% oil, and optionally other ingredients such as powders, sunscreens, and the like, with all percentages meaning percent by weight unless otherwise indicated.
  • the composition may comprise from about 1-99% water, and optionally other ingredients.
  • the composition may comprise from about 0.1% to about 99%, preferably from about 5% to about 95%, more preferably from about 7% to about 90% water and from about 0.1% to 99%, preferably from about 5% to about 95%, more preferably from about 7% to about 90% oil or silicone.
  • compositions that the present invention covers include, but are not limited to: mascara, blush, eye shadow, eyeliner, skin cream, skin lotion, skin treatment serum, foundation, lipstick, lip gloss, and the like.
  • Such compositions may include various cosmetic or skin care ingredients, as described hereinafter:
  • the cosmetic or skin care compositions of the present invention may contain one or more oils which may be volatile or non-volatile.
  • oils refers to an ingredient that is pourable at room temperature (e.g. 25° C.)
  • volatile means that the oil has a vapor pressure of greater than about 2 mm. of mercury at 20° C.
  • Volatile oils may include silicones or paraffinic hydrocarbons. If present, such volatile oils may range from about 0.1 to 50%.
  • volatile silicones examples include linear silicones such as hexamethyldisiloxane (0.5 centistokes (cs)), octamethyltrisiloxane (1.0 cs), decamethyltetrasiloxane (1.5 cs), dodecamethylpentasiloxane (2.0 cs); or cyclic volatile silicones generally referred to as “cyclomethicone”, which may be octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, and so on.
  • volatile paraffinic hydrocarbons examples include isohexadecane, isododecane, C9-11 isoparaffins, and the like.
  • Nonvolatile oils may include silicones, hydrocarbons, or esters.
  • the term “nonvolatile” means that the oil has a vapor pressure of less than about 2 mm. of mercury at 20° C.
  • Examples of nonvolatile silicones include dimethicone or diethicone; phenyl-substituted silicones such as phenyl trimethicone, diphenyl dimethicone, phenyl dimethicone, trimethylsiloxyphenyl dimethicone, phenethyl dimethicone; and the like; C2-14 alkyl substituted silicones such as cetyl dimethicone, hexyl dimethicone, lauryl dimethicone; or fluorinated silicones such as perfluorononyl dimethicone, trifluoropropyl dimethicone; and the like.
  • non-volatile hydrocarbons include hydrocarbons having from 10 to 40 carbon atoms in the linear or branched form such as C10-40 isoparaffins, C12-20 isoparaffins; or olefins having from about 18 to 54 carbon atoms, for example C18-26 olefin, C20-24 olefin, C26-54 olefin; polybutene, polyisobutene, polydecene, or hydrogenated derivatives thereof such as hydrogenated polyisobutene; isoeicosane; squalane; squalene; and so on.
  • hydrocarbons having from 10 to 40 carbon atoms in the linear or branched form such as C10-40 isoparaffins, C12-20 isoparaffins; or olefins having from about 18 to 54 carbon atoms, for example C18-26 olefin, C20-24 olefin, C26-54 olefin; polybutene, polyis
  • esters include those formed by the reaction of mono-, di-, or polyhydric C1-10 alcohols with carboxylic acids having from about 1 to 40 carbon atoms, preferably fatty C6-22 carboxylic acids.
  • Preferred alcohols include ethanol, propanol, butanol, hexanol, glycerin, and so on.
  • Preferred carboxylic acids include myristic, stearic, isostearic, palmitic, behenic, and so on.
  • One particularly preferred ester is formed by the reaction of a polyhydric alcohol with fatty carboxylic acids, more specification glycerin and stearic acid, to provide glyceryl stearate, diglyceryl diisostearate, glyceryl triisostearate, and so on. Most preferred is glyceryl stearate.
  • the cosmetic or skin care compositions of the present invention may comprise at least one film former which is capable of forming a film when applied to the skin surface. If present, suggested ranges of film former(s) are from about 0.1 to 45%, preferably from about 0.5 to 40%, more preferably from about 0.5 to 30%. Film formers may be synthetic or natural polymers. They may be water soluble or oil soluble. They may be in the form of particles in aqueous dispersion, or solubilized or dispersed in the lipophilic phase of the composition.
  • film forming polymers include polyurethanes either in lipophilic form or in the form of particles in aqueous dispersion; copolymers from ethylenically unsaturated monomers, for example, homo- or copolymers of acrylates, ammonium acrylates, styrene, acrylamides, methacrylates, vinyl acetate, vinyl pyrrolidone; or siloxy silicate polymers such as trimethylsiloxysilicate, polymethylsilsesquioxane; or silicone gums which are general dimethicone or dimethiconol having a degree of polymerization ranging from about 100,000 to 100 million cs.
  • film forming polymers include, but are not limited to, acrylates copolymer, polyurethane, acrylamide/ammonium acrylate copolymer, acrylamides copolymer, acrylates/acrylamide copolymer, acrylates/ammonium methacrylate copolymer, acrylates/octylacrylamide copolymer, PVP, PVA, PVP/VA copolymer, acrylates/VA copolymer, acrylates/VP copolymer, ammonium styrene/acrylates copolymer, and so on.
  • Naturally occurring polymers such as shellac or cellulose.
  • the film former is shellac in aqueous dispersion which comprises from about 10-70% water, 1-40% shellac, and optionally from about 0.1-40% of a monohydric alcohol (preferably isopropanol or ethanol) and from about 0.0001 to 10% of a neutralizer which may be ammonium hydroxide.
  • a monohydric alcohol preferably isopropanol or ethanol
  • a neutralizer which may be ammonium hydroxide.
  • the film former comprises a vinyl pyrrolidone homo- or copolymer such as PVP, PVP/VA copolymer and so on.
  • the cosmetic or skin care compositions of the present invention may also contain at least one structuring agent which increases the viscosity or thickens the composition. If present, suggested ranges of structuring agent(s) are from about 0.1-70%, preferably from about 0.5-65%, more preferably from about 1-60%.
  • Structuring agents may be natural or synthetic waxes, polymeric materials that increase viscosity, and the like.
  • waxes examples include polyethylene, polypropylene, beeswax, beeswax modified by reacting with polyethylene glycol, such as PEG-8 beeswax, PEG-10 beeswax, carnauba, ceresin, microcrystalline, or fatty alcohols such as stearyl, behenyl; or fatty acids such as stearic acid, behenic acid, isostearic acid, and so on.
  • polyamides or silicone polyamides are also suitable as silicone polyamides.
  • Examples include those sold by Arizona Chemical under the trademarks Sylvaclear® and Uniclear®, including those having the INCI names ethylenediamine/stearyl dimer tallate copolymer or ethylenediamine/stearyl dimer dilinolate copolymer, ethylenediamine/dimer tallate copolymer bis-hydrogenated tallow amide; Polyamide-3; ethylenediamine/hydrogenated dimer dilinoleate copolymer bis-di-C14-18 alkyl amide; Polyamide-4; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer and the like.
  • Silicone waxes may also be used including but not limited to stearyl dimethicone, behenyl dimethicone, behenoxy dimethicone, stearoxy dimethicone, and so on.
  • stearyl dimethicone behenyl dimethicone, behenoxy dimethicone, stearoxy dimethicone, and so on.
  • structuring agents are N-acyl amino acids or esters or amides thereof; 12-hydroxystearic acid or esters or amides thereof; fatty acid esters of di- or trifunctional alcohol dimers; or alkylamides of di- or tricarboxylic acids. Examples include stearamide MEA-stearate, N-acyl glutamic acid diamide, and so on.
  • Also suitable as structuring agents are naturally occurring ingredients that increase viscosity such as gums, including but not limited to Acacia Senegal gum, Veegum (magnesium aluminum silicate), biosaccharide gum, Boswellia Serrata gum, Cassia gum, cellulose gum, Gellan gum, xanthan gum, algin, agarose, cellulose, hydroxyethylcellulose, and the like.
  • gums including but not limited to Acacia Senegal gum, Veegum (magnesium aluminum silicate), biosaccharide gum, Boswellia Serrata gum, Cassia gum, cellulose gum, Gellan gum, xanthan gum, algin, agarose, cellulose, hydroxyethylcellulose, and the like.
  • Silicone elastomers are also suitable structuring agents and include those that are formed by addition reaction-curing, by reacting an SiH-containing diorganosiloxane and an organopolysiloxane having terminal olefinic unsaturation, or an alpha-omega diene hydrocarbon, in the presence of a platinum metal catalyst.
  • Suitable silicone elastomers for use in the compositions of the invention may be in the powder form, or dispersed or solubilized in solvents such as volatile or non-volatile silicones, or silicone compatible vehicles such as paraffinic hydrocarbons or esters.
  • silicone elastomer powders include vinyl dimethicone/methicone silsesquioxane crosspolymers like Shin-Etsu's KSP-100, KSP-101, KSP-102, KSP-103, KSP-104, KSP-105, hybrid silicone powders that contain a fluoroalkyl group like Shin-Etsu's KSP-200 which is a fluoro-silicone elastomer, and hybrid silicone powders that contain a phenyl group such as Shin-Etsu's KSP-300, which is a phenyl substituted silicone elastomer; and Dow Corning's DC 9506.
  • silicone elastomer powders dispersed in a silicone compatible vehicle examples include dimethicone/vinyl dimethicone crosspolymers supplied by a variety of suppliers including Dow Corning Corporation under the tradenames 9040 or 9041, GE Silicones under the tradename SFE 839, or Shin-Etsu Silicones under the tradenames KSG-15, 16, 18.
  • KSG-15 has the CTFA name cyclopentasiloxane/dimethicone/vinyl dimethicone crosspolymer.
  • KSG-18 has the INCI name phenyl trimethicone/dimethicone/phenyl vinyl dimethicone crosspolymer.
  • Silicone elastomers may also be purchased from Grant Industries under the Gransil trademark. Also suitable are silicone elastomers having long chain alkyl substitutions such as lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu under the tradenames KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44.
  • Cross-linked organopolysiloxane elastomers useful in the present invention and processes for making them are further described in U.S. Pat. No. 4,970,252 to Sakuta et al., issued Nov. 13, 1990; U.S. Pat. No. 5,760,116 to Kilgour et al., issued Jun.
  • the cosmetic or skin care compositions of the present invention may also contain one or more aqueous phase thickeners. If present, suggested ranges are from about 0.1-30%, preferably from about 0.5-25%, more preferably from about 0.5-20%.
  • Suitable thickeners include acrylic polymeric thickeners comprised of monomers of acrylic acid, methacrylic acid, or their simple C 1-22 alkyl esters.
  • Acrylic polymer solutions include those sold by Seppic, Inc., under the tradename Capigel having the CTFA name Acrylates Copolymer.
  • acrylic polymeric thickeners that are copolymers of acrylic acid, methacrylic acid or their C 1-22 alkyl esters further copolymerized with one or more fatty alkoxylated alcohols.
  • thickening agents include acrylates/steareth-20 methacrylate copolymer, which is sold by Rohm & Haas under the tradename Acculyn 22, or acrylates/steareth-20/methacrylate crosspolymer which may be purchased from Rohm & Haas under the tradename Acculyn 88.
  • acrylate based anionic amphiphilic polymers containing at least one hydrophilic unit and at least one allyl ether unit containing a fatty chain.
  • the hydrophilic unit contains an ethylenically unsaturated anionic monomer, more specifically a vinyl carboxylic acid such as acrylic acid, methacrylic acid or mixtures thereof, and where the allyl ether unit containing a fatty chain corresponds to the monomer of formula:
  • R′ denotes H or CH 3
  • B denotes the ethyleneoxy radical
  • n is zero or an integer ranging from 1 to 100
  • R denotes a hydrocarbon radical selected from alkyl, arylalkyl, aryl, alkylaryl and cycloalkyl radicals which contain from 8 to 30 carbon atoms, preferably from 10 to 24, and even more particularly from 12 to 18 carbon atoms. More preferred in this case is where R′ denotes H, n is equal to 10 and R denotes a stearyl (C18) radical.
  • Anionic amphiphilic polymers of this type are described and prepared in U.S. Pat. Nos.
  • anionic amphiphilic polymers polymers formed of 20 to 60% by weight acrylic acid and/or methacrylic acid, of 5 to 60% by weight lower alkyl methacrylates, of 2 to 50% by weight allyl ether containing a fatty chain as mentioned above, and of 0 to 1% by weight of a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, for instance diallyl phthalate, allyl (meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate and methylenebisacrylamide.
  • a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, for instance diallyl phthalate, allyl (meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate and methylenebisacrylamide.
  • polymers are crosslinked terpolymers of methacrylic acid, of ethyl acrylate, of polyethylene glycol (having 10 EO units) ether of stearyl alcohol or steareth-10, in particular those sold by the company Allied Colloids under the names SALCARE SC80 and SALCARE SC90, which are aqueous emulsions containing 30% of a crosslinked terpolymer of methacrylic acid, of ethyl acrylate and of steareth-10 alkyl ether (40/50/10).
  • acrylate copolymers such as Polyacrylate-3 which is a copolymer of methacrylic acid, methylmethacrylate, methylstyrene isopropylisocyanate, and PEG-40 behenate monomers; Polyacrylate-10 which is a copolymer of sodium acryloyldimethyltaurate, sodium acrylate, acrylamide and vinyl pyrrolidone monomers; or Polyacrylate-11, which is a copolymer of sodium acryloyldimethylacryloyldimethyl taurate, sodium acrylate, hydroxyethyl acrylate, lauryl acrylate, butyl acrylate, and acrylamide monomers.
  • Polyacrylate-3 which is a copolymer of methacrylic acid, methylmethacrylate, methylstyrene isopropylisocyanate, and PEG-40 behenate monomers
  • Polyacrylate-10 which is a copolymer of sodium acryloyldi
  • crosslinked acrylate based polymers where one or more of the acrylic groups may have substituted long chain alkyl (such as 6-40, 10-30, and the like) groups, for example acrylates/C 10-30 alkyl acrylate crosspolymer which is a copolymer of C10-30 alkyl acrylate and one or more monomers of acrylic acid, methacrylic acid, or one of their simple esters crosslinked with the allyl ether of sucrose or the allyl ether of pentaerythritol.
  • Such polymers are commonly sold under the Carbopol or Pemulen tradenames.
  • acrylate based polymeric thickeners sold by Clariant under the Aristoflex trademark such as Aristoflex AVC, which is ammonium acryloyldimethyltaurate/VP copolymer; Aristoflex AVL which is the same polymer has found in AVC dispersed in mixture containing caprylic/capric triglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate; or Aristoflex HMB which is ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer, and the like.
  • Aristoflex AVC ammonium acryloyldimethyltaurate/VP copolymer
  • Aristoflex AVL which is the same polymer has found in AVC dispersed in mixture containing caprylic/capric triglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate
  • Aristoflex HMB ammonium acryloyldimethylt
  • aqueous phase thickening agents are various polyethylene glycols (PEG) derivatives where the degree of polymerization ranges from 1,000 to 200,000. Such ingredients are indicated by the designation “PEG” followed by the degree of polymerization in thousands, such as PEG-45M, which means PEG having 45,000 repeating ethylene oxide units.
  • PEG derivatives include PEG 2M, 5M, 7M, 9M, 14M, 20M, 23M, 25M, 45M, 65M, 90M, 115M, 160M, 180M, and the like.
  • polyglycerins which are repeating glycerin moieties where the number of repeating moieties ranges from 15 to 200, preferably from about 20-100.
  • suitable polyglycerins include those having the CFTA names polyglycerin-20, polyglycerin-40, and the like.
  • aqueous phase thickening agents are various types of polysaccharides, such as xanthan gum, cellulose, dextrin, cyclodextrin, hydroxyethylcellulose, acacia gum, and the like.
  • the cosmetic or skin care compositions of the present invention may further comprise at least one emulsifier or surfactant. If present, suggested ranges of such emulsifier(s) or surfactant(s) are from about 0.01-40%, preferably from about 0.05-35%, more preferably from about 0.1-25%.
  • Suitable emulsifiers may be silicone based emulsifiers or surfactants including linear or crosslinked polyoxyalkylene substituted organosiloxanes or alkyl substituted polyoxyalkylene organosiloxanes. Examples include those having the generic name dimethicone copolyol, cetyl dimethicone copolyol, and so on.
  • silicone surfactants are those sold by Dow Corning under the tradename Dow Corning 3225C Formulation Aid having the CTFA name cyclotetrasiloxane (and) cyclopentasiloxane (and) PEG/PPG-18 dimethicone; or 5225C Formulation Aid, having the CTFA name cyclopentasiloxane (and) PEG/PPG-18/18 dimethicone; or Dow Corning 190 Surfactant having the CTFA name PEG/PPG-18/18 dimethicone; or Dow Corning 193 Fluid, Dow Corning 5200 having the CTFA name lauryl PEG/PPG-18/18 methicone; or Abil EM 90 having the CTFA name cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil EM 97 having the CTFA name bis-cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil WE 09 having the CTFA name cetyl PEG/
  • crosslinked silicone surfactants that are often referred to as emulsifying elastomers. They are typically prepared as set forth above with respect to the section “silicone elastomers” except that the silicone elastomers will contain at least one hydrophilic moiety such as polyoxyalkylenated groups.
  • these polyoxyalkylenated silicone elastomers are crosslinked organopolysiloxanes that may be obtained by a crosslinking addition reaction of diorganopolysiloxane comprising at least one hydrogen bonded to silicon and of a polyoxyalkylene comprising at least two ethylenically unsaturated groups.
  • the polyoxyalkylenated crosslinked organo-polysiloxanes are obtained by a crosslinking addition reaction of a diorganopolysiloxane comprising at least two hydrogens each bonded to a silicon, and a polyoxyalkylene comprising at least two ethylenically unsaturated groups, optionally in the presence of a platinum catalyst, as described, for example, in U.S. Pat. No. 5,236,986 and U.S. Pat. No. 5,412,004, U.S. Pat. No. 5,837,793 and U.S. Pat. No. 5,811,487, the contents of which are incorporated by reference.
  • Polyoxyalkylenated silicone elastomers that may be used in at least one embodiment of the invention include those sold by Shin-Etsu Silicones under the names KSG-21, KSG-20, KSG-30, KSG-31, KSG-32, KSG-33; KSG-210 which is dimethicone/PEG-10/15 crosspolymer dispersed in dimethicone; KSG-310 which is PEG-15 lauryl dimethicone crosspolymer; KSG-320 which is PEG-15 lauryl dimethicone crosspolymer dispersed in isododecane; KSG-330 (the former dispersed in triethylhexanoin), KSG-340 which is a mixture of PEG-10 lauryl dimethicone crosspolymer and PEG-15 lauryl dimethicone crosspolymer.
  • polyglycerolated silicone elastomers like those disclosed in PCT/WO 2004/024798, which is hereby incorporated by reference in its entirety.
  • elastomers include Shin-Etsu's KSG series, such as KSG-710 which is dimethicone/polyglycerin-3 crosspolymer dispersed in dimethicone; or lauryl dimethicone/polyglycerin-3 crosspolymer dispersed in a variety of solvent such as isododecane, dimethicone, triethylhexanoin, sold under the Shin-Etsu tradenames KSG-810, KSG-820, KSG-830, or KSG-840.
  • silicones sold by Dow Corning under the tradenames 9010 and DC9011.
  • the composition may comprise one or more nonionic organic surfactants.
  • Suitable nonionic surfactants include alkoxylated alcohols, or ethers, formed by the reaction of an alcohol with an alkylene oxide, usually ethylene or propylene oxide.
  • the alcohol is either a fatty alcohol having 6 to 30 carbon atoms.
  • Steareth 2-100 which is formed by the reaction of stearyl alcohol and ethylene oxide and the number of ethylene oxide units ranges from 2 to 100
  • Beheneth 5-30 which is formed by the reaction of behenyl alcohol and ethylene oxide where the number of repeating ethylene oxide units is 5 to 30
  • Ceteareth 2-100 formed by the reaction of a mixture of cetyl and stearyl alcohol with ethylene oxide, where the number of repeating ethylene oxide units in the molecule is 2 to 100
  • Ceteth 1-45 which is formed by the reaction of cetyl alcohol and ethylene oxide, and the number of repeating ethylene oxide units is 1 to 45, and so on.
  • alkoxylated alcohols are formed by the reaction of fatty acids and mono-, di- or polyhydric alcohols with an alkylene oxide.
  • Examples include polymeric alkylene glycols reacted with glyceryl fatty acid esters such as PEG glyceryl oleates, PEG glyceryl stearate; or PEG polyhydroxyalkanoates such as PEG dipolyhydroxystearate wherein the number of repeating ethylene glycol units ranges from 3 to 1000.
  • ethoxylated propoxylated derivatives of C6-30 saturated or unsaturated fatty acids for example, Di-PPG-2 myreth-10 adipate, Di-PPG-2 Ceteth-4 adipate, Di-PPG Myristyl Ether Adipate,
  • nonionic surfactants are formed by the reaction of a carboxylic acid with an alkylene oxide or with a polymeric ether.
  • the resulting products have the general formula: where RCO is the carboxylic ester radical, X is hydrogen or lower alkyl, and n is the number of polymerized alkoxy groups. In the case of the diesters, the two RCO-groups do not need to be identical.
  • R is a C6-30 straight or branched chain, saturated or unsaturated alkyl, and n is from 1-100.
  • Monomeric, homopolymeric, or block copolymeric ethers are also suitable as nonionic surfactants.
  • ethers are formed by the polymerization of monomeric alkylene oxides, generally ethylene or propylene oxide.
  • Such polymeric ethers have the following general formula: wherein R is H or lower alkyl and n is the number of repeating monomer units, and ranges from 1 to 500.
  • Suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives.
  • alkoxylation, in particular ethoxylation of sorbitan provides polyalkoxylated sorbitan derivatives.
  • Esterification of polyalkoxylated sorbitan provides sorbitan esters such as the polysorbates.
  • the polyalkoxylated sorbitan can be esterified with C6-30, preferably C12-22 fatty acids. Examples of such ingredients include Polysorbates 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and so on.
  • organic emulsifiers that are the reaction product of polyethylene glycol with fatty acids, e.g. PEG1-200 with stearic, isostearic, myristic, behenic, cetearic, acids and so on.
  • Particulately preferred is where the emulsifier comprises the reaction product of polyethylene glycol and stearic acid, e.g. PEG-100 stearate.
  • derivatives of sorbitan such as Polysorbates; sorbitan esterified with stearic acid, e.g. sorbitan tristearate, and so on.
  • the cosmetic or skin care compositions may further comprise particulates, either in the from of pigments, powders or mixtures.
  • Suitable pigments include inorganic pigments or iron oxides that are red, yellow, or black. Also suitable are organic pigments that are FD&C or D&C colors or Lakes thereof such as yellows, reds, blues, etc.
  • Suitable powders include titanium dioxide, mica, bismuth oxychloride, titanated mica, PTFE, silica, bentonite, kaolin, talc, and the like. If present, suggested ranges of pigments are from about 0.01-45%, preferably from about 0.05-35%. Suggested ranges of powders are from about 0.01-10%.
  • the cosmetic or skin care compositions of the present invention may also contain one or more humectants. If present, suggested ranges of the humectant(s) are from about 0.1 to 25%.
  • Humectants include glycols, sugars, and the like. Suitable glycols are in monomeric or polymeric form and include polyethylene and polypropylene glycols such as PEG 4-200, which are polyethylene glycols having from 4 to 200 repeating ethylene oxide units; as well as C 1-6 alkylene glycols such as propylene glycol, butylene glycol, pentylene glycol, and the like.
  • Suitable sugars, some of which are also polyhydric alcohols, are also suitable humectants.
  • sugars examples include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, trehalose, and so on.
  • urea or sugar derivatives e.g. ethylhexylglycerin.
  • the humectants used in the composition of the invention are C 1-6 , preferably C 2-4 alkylene glycols, most particularly butylene glycol.
  • compositions may further contain other ingredients including but not limited to preservatives, sunscreens, and so on.
  • Fine powder containing a blend of plant extracts for maintaining and strengthening the Yin-Yang balance of a user with balanced skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Fine powder containing a blend of plant extracts for nourishing the Yin energy and balancing/neutralizing the excess Yang energy of a user with Yang-dominant skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Fine powder containing a blend of plant extracts for nourishing the Yang energy and balancing/neutralizing the excess Yin energy of a user with Yin-dominant skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Rhodiola rosea rhizome 28.13% Perilla frutescens fruit 9.38% Phellodendron amurense bark 9.38% Foeniculum vulgare seed 3.13% Santalum album stem 3.13% Hordeum distichon seed 28.10% Citrus reticulata peel 18.75% Total 100.00%
  • Fine powder containing a blend of plant extracts for treating dark circles, puffiness, and wrinkles around the eye areas of a user was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • a sterilized cultural medium containing an aqueous solution of Difco malt extract broth at 1.5 wt % or 15 grams/liter was inoculated with Saccharomyces cerevisiae (baker's yeast) at about 24° C. for about 14 hours, until the yeast reached the end of log phase growth, to form an inoculum.
  • Fine powder containing a blend of plant extracts as described hereinabove in Examples 1-4 was then added into a New Brunswick Scientific Bioflo 6000 reactor/fermentor of about 100 liters in volume, together with the inoculum and various ingredients described at below:
  • Odors of the blends of plant extracts as described hereinabove in Examples 1-4 before and after the fermentation process of Example 5 were compared using an Alpha M.O.S. Fox electronic nose system. Specifically, a 1 mL aliquot of each sample was prepared in quadruplicate and ran on the electronic nose at about 45° C. and for about 250 or 450 seconds. The data obtained for each sample was plotted using the PSA model. In all cases, the PSA data showed observable difference between the TCM blends before fermentation and after fermentation. Further, smell tests conducted by human subjects confirmed a reduction of undesirable odor in TCM blends after fermentation, in comparison with the same blends before fermentation.

Abstract

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This claims priority to U.S. Provisional Patent Application No. 61/159,272 filed Mar. 11, 2009 and U.S. Provisional Patent Application No. 61/228,999 filed Jul. 28, 2009.
  • FIELD OF THE INVENTION
  • The present invention relates to topical compositions for improving the appearance and skin condition of a user, while such topical compositions contain fermented extracts of Traditional Chinese Medicinal (TCM) ingredients with reduced color and odor. The present invention also relates to computer-based system and method for determining the skin composition of a specific user and selecting a suitable topical composition for such user based on his or her skin composition according to TCM principles.
  • BACKGROUND OF THE INVENTION
  • There is great interest in the cosmetic industry to develop products containing natural plant-derived materials that may be applied topically to the skin to provide anti-acne, anti-oil, and anti-cellulite benefits. Plant-based cosmetic products that enhance the appearance of skin are increasingly in demand. Active ingredients or components with skin care benefits can be obtained from either the entire plant or various parts of a plant, such as seeds, needles, leaves, roots, bark, cones, stems, rhizomes, callus cells, protoplasts, organs and organ systems, and meristems, either as dried powders or liquid extracts, which can then be incorporated into topical compositions.
  • Traditional Chinese Medicine (hereinafter “TCM”) has been in existence for several thousands of years and is based largely on accumulated human experience in using naturally occurring plant and animal extracts to treat various diseases. In recently years, TCM practices have gained significant recognition by the Western world, especially for treatment of chronic pathological conditions. Certain TCM ingredients have been known to have skin care benefits for thousands of years, and cosmetic or skin care products containing such TCM ingredients are becoming more popular. Because the TCM ingredients are all natural, they are significantly more appealing to customers who are conscious of the side effects and adverse environmental impacts of synthetic compounds.
  • However, it is important to note that the basic principles of TCM are quite different from that of the western medicinal sciences. For example, TCM believes that an internal physiological balance has to be maintained for a person to be healthy, and all diseases are caused by one or more types of imbalances, and each type of imbalances manifests through an identifiable pattern of symptom and requires a particular set of treatments for correction. A TCM practitioner typically uses a compound prescription containing a blend of multiple herbal ingredients to treat various symptoms of a disease after careful examination of an individual patient, and such prescription is specifically designed for the patient to re-establish the internal physiological balance of such patient. In other words, the TCM practice takes an individualized treatment approach, instead of a “one-size-fits-all” treatment approach.
  • Unfortunately, the currently available skin care products containing naturally occurring TCM ingredients are mass-marketed to all consumers and fail to implement the individualized treatment approach of TCM. Therefore, it would be desirable to provide new cosmetic and skin care products containing TCM ingredients that adopt the individualized treatment approach of TCM in improving the appearance and skin condition of specific users.
  • Further, a problem commonly encountered when formulating TCM ingredients into cosmetic or skin care products is the distinctive color and undesirable odor associated with many TCM ingredients, which makes it difficult to form aesthically and olfactorily acceptable cosmetic or skin care compositions containing such TCM ingredients. It would also be desirable to process TCM ingredients by reducing the color and odor so that they can be readily formulated into aesthically and olfactorily acceptable cosmetic or skin care compositions.
  • SUMMARY OF THE INVENTION
  • The present invention provides topical compositions, each of which contains a unique blend of TCM ingredients specifically designed to improve the appearance and skin conditions of a particular sub-population of users characterized by a specific skin composition, according to the TCM principles. Specifically, one aspect of the present invention relates to a topical composition containing fermented extracts of Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel, which can be applied to the skin of a user with a balanced skin composition to improve the appearance and skin conditions of said user. Another aspect of the present invention relates to a topical composition containing fermented extracts of Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower, which can be applied to the skin of a user with a Yang-dominant or balanced-to-Yang skin composition to nourish Yin and store the Yin-Yang balance in the skin. A further aspect of the present invention relates to a topical composition containing fermented extracts of Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed, which can be applied to the skin of a user with a Yin-dominant or balanced-to-Yin skin composition to nourish Yin and store the Yin-Yang balance in the skin.
  • The present invention also provides a method for preparing a topical composition by first fermenting a blend of extracts from one or more TCM ingredients known to have undesirable odor and/or color in the presence of an aerobically metabolizing microorganism under suitable aerobic conditions for a period of time sufficient to reduce or eliminate the undesirable odor and/or color while preserving desirable biological activities of said TCM ingredients, and then formulating the fermented blend of TCM extracts into a cosmetically or pharmaceutically acceptable carrier to form said topical composition.
  • Further, the present invention provides a method for selecting a topical composition for a user to improve the appearance or skin condition of said user based on his or her skin composition, comprising: (a) collecting biological data from the user; (b) categorizing the skin composition of the user based on the collected biological data, wherein said categorization is indicative of the Yin-Yang balance of the skin or the lack thereof; and (c) selecting a topical composition for the user, wherein said topical composition contains a blend of fermented Chinese herbal extracts for maintaining or restoring the Yin-Yang balance of the skin. Preferably, the skin composition of the user is categorized by using a statistical model that weights the biological data according to TCM principles.
  • Other aspects and objectives of the present invention will become more apparent from the ensuring description, examples, and claims.
  • DETAILED DESCRIPTION OF THE INVENTION, AND PREFERRED EMBODIMENT THEREOF
  • The present invention provides several topical compositions, each of which contains a unique combination of fermented extracts of TCM ingredients for targeting a sub-population of users with a specific skin composition according to the TCM principles. In TCM practices, health is represented as a balance of Yin and Yang, which are opposing forces interconnected and interdependent in the natural world, giving rise to each other in turn. These two forces represent the bipolar manifestation of all things in nature, and because of this, one must be present to allow the other to exist. A constantly changing balance between Yin and Yang should be maintained within the body of a person. When one force is regularly dominating over the other, the health of the patient can become compromised, resulting in illness and disease. Therefore, when diagnosing a patient, TCM practitioners usually try to determine the exact nature of the Yin/Yang imbalance, and then correct it through the use of acupuncture, herbal remedies, exercise, diet and lifestyle. Once the balance is restored in the body, so is health.
  • Correspondingly, the topical compositions provided by the present invention are specifically designed for different sub-population of users with different skin compositions, which can be categorized according to the Yin and Yang balance/imbalance of the skin. For example, the skin compositions can be divided into three major categories: the Yin-Yang balanced skin composition (hereinafter referred to as “balanced skin composition”), the Yang-dominant skin composition, and the Yin-dominant skin composition. Additional categories can also be included to further quantify the degree of imbalance. For example, the skin composition categorization may further include a balance-to-Yang skin composition and a balance-to-Yin skin composition, which are relatively balanced skin compositions with slight Yang or Yin symptoms.
  • The specific skin composition of a patient can be determined by observing the skin condition, tongue color and tongue fur color of the patient (which are two important factors to be considered by TCM practitioners for diagnosis), as well as by gathering certain information from the patient regarding the person's age, bodily sensation, sleep pattern, and energy level. For example, the balanced skin composition is typically characterized by smooth, radiant, soft and delicate skin with good elasticity and even skin tone, and patients with the balanced skin composition usually also have lips and tongue of light red color with thin, pale white tongue fur color. The Yang-dominant skin composition is typically characterized by reddish cheek and red skin tone, oily skin surface, and tendency to develop allergy, acne, pigmentation, and pre-mature wrinkles. Patients with the Yang-dominant skin composition may also have lips and tongue of bright red color with yellow tongue fur color, and they typically prefer cold drinks, become thirsty very easily, have bitter tastes in the mouth, often sweat when sleeping at night, easily irascible, and often suffer from internal heat. The Yin-dominant skin composition is typically characterized by pale skin tone, dry and easily desquamated skin with low water absorption and water retention capacity, and tendency to develop pigmentation and pre-mature wrinkles. Patients with the Yin-dominant skin composition may have pale or blue lips, light red or pale tongue color with white tongue fur color, and they typically prefer hot drinks, have relatively cold hands and feet, are sensitive to temperature decrease, and often feel tired or sleepy. Patients with balanced-to-Yang or balanced-to-Yin skin composition may exhibit similar symptoms as those with Yang-dominant or Yin-dominant skin composition but to a lesser degree.
  • Correspondingly, the present invention provides a method for selecting cosmetic or skin care products for users based on their specific skin compositions, by first collecting biological data (e.g., age, bodily sensation, sleep pattern, energy level, tongue color, tongue fur color, and skin condition of the user), then determining the skin composition of the user based on the collected biological data, and finally selecting a suitable cosmetic or skin care product for the user corresponding to his or her skin composition. Preferably, the biological data was collected by a preliminary facial examination of the user as well as requesting the user to fill out a questionnaire, and the data so collected is then processed by a computer-based system programmed with a statistical model for specifically for determining the skin compositions of a user by weighing the collected biological data according to TCM principles.
  • Unlike the Western medicinal science that typically uses one drug to treat one disease, the TCM practice adopts a compound or combinational approach in its herbal therapy, i.e., by using a blend of different herbal ingredients to target the root cause as well as different symptoms of the disease. A typical TCM formula contains four major ingredients, each playing its unique role while working together synergistically to achieve the optimal treatment results. The four major ingredients have been described in ancient texts as “emperor” or “king,” “minister,” “assistant” and “servant.” This TCM philosophy models these four major ingredients components in a compound formula after a court of an emperor. The emperor or king ingredient serves as the principle in attacking the root cause of the disease; the minister ingredient acts to assist and augment the emperor or king ingredient; the assistant ingredient also assists the emperor or king ingredient, but it focuses on counter-reacting any possible side-effects of the emperor or king ingredient; and the servants ingredient acts to deliver the medicine where it should go. Sometimes, a single ingredient may perform double or triple duties in a single TCM herbal formula, e.g., both as the king and the minister, or as the king, the minister and the assistant, or the like. Correspondingly, the TCM herbal formula may have only 2 or 3 ingredients in total.
  • In the present invention, a blend of fermented plant extracts containing at least four, and preferably seven, ingredients is provided for users with a balanced skin composition to maintain and strengthen the balance between Yin and Yang in the patient's skin, improve the immune system and the skin barrier function of the patient, revitalize the skin, and enhance self-repair function of the skin. Such a blend contains fermented extracts from Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel. The Cordyceps sinensis mycelia extract functions as the emperor or king ingredient in this blend; the Ginkgo biloba leaf extract functions as the minister ingredient; the Polygonum cuspidatum rhizome extract functions as the assistant ingredient; and the Citrus reticulata peel extract functions as the servant ingredient. Preferably, this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Poria cocos sclerotium, Panax ginseng root, and Perilla frutescens fruit, and most preferably, it comprises all three additional minister ingredients.
  • The fermented extract of Cordyceps sinensis mycelia is preferably present in this blend at an amount ranging from about 10% to about 40%, more preferably from about 15% to about 35%, and most preferably from about 20% to about 30%, by total weight of the blend. The fermented extract of Ginkgo biloba leaf is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend. The fermented extract of Polygonum cuspidatum rhizome is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend. The fermented extract of Citrus reticulata peel is preferably present in this blend at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend. If present, the fermented extract of Poria cocos sclerotium is preferably at an amount ranging from about 10% to about 40%, more preferably from about 15% to about 35%, and most preferably from about 20% to about 30%, by total weight of the blend. If present, the fermented extract of Panax ginseng root is preferably at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 3% to about 5%, by total weight of the blend. If present, the Perilla frutescens fruit is preferably at an amount ranging from about 2% to about 30%, more preferably from about 5% to about 20%, and most preferably from about 10% to about 15%, by total weight of the blend.
  • For users with a Yang-dominant or balanced-to-Yang skin composition, the present invention provides a blend of fermented plant extracts containing at least four, and preferably seven, ingredients to nourish the Yin energy in the skin, balance/neutralize the excess Yang energy, promote metabolism in the skin, facilitate circulation of bodily fluid as well as transportation of any turbid Qi (which is believed to be the cause of various diseases in TCM theories), regulate the immune system, improve the skin barrier function, and enhance the self-repair function of the skin. Such a blend contains fermented extracts from Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower. The Ganoderma lucidum fruiting body extract functions as the emperor or king ingredient in this blend; the Selaginella tamariscina plant functions as the minister ingredient; the Ginkgo biloba leaf extract functions as the assistant ingredient; and the Calendula officinalis flower extract functions as the servant ingredient. Preferably, this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Centella asiatica plant, Scutellaria baicalensis root, and Polygonum cuspidatum rhizome, and most preferably, it comprises all three additional minister ingredients.
  • The fermented extract of Ganoderma lucidum fruiting body is preferably present in this blend at an amount ranging from about 10% to about 45%, more preferably from about 15% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend. The fermented extract of Selaginella tamariscina plant is preferably present in this blend at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend. The fermented extract of Ginkgo biloba leaf is preferably present in this blend at an amount ranging from about 0.1% to about 20%, more preferably from about 1% to about 15%, and most preferably from about 3% to about 10%, by total weight of the blend. The fermented extract of Calendula officinalis flower is preferably present in this blend at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend. If present, the fermented extract of Centella asiatica plant is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend. If present, the fermented extract of Scutellaria baicalensis root is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend. If present, the Polygonum cuspidatum rhizome is preferably at an amount ranging from about 2% to about 35%, more preferably from about 5% to about 25%, and most preferably from about 10% to about 15%, by total weight of the blend. This blend of fermented plant extracts is used to balance both the Yang-dominant skin composition and the balanced-to-Yang skin composition, but at different concentrations. For example, the concentrations of fermented plant extracts in products designated for the balanced-to-Yang skin composition are preferably from 25% to 75%, more preferably from about 40% to about 60%, of those in products designated for the Yang-dominant skin composition.
  • For users with a Yin-dominant or balanced-to-Yin skin composition, the present invention provides a blend of fermented plant extracts containing at least four, and preferably seven, ingredients to nourish the Yang energy in the skin, balance/neutralize the excess Yin energy, strengthen the body fluid circulation, improve the immune system, enhance the skin barrier function, and enhance the self-repair function of the skin. Such a blend contains fermented extracts from Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed. The Rhodiola rosea rhizome extract functions as the emperor or king ingredient in this blend; the Perilla frutescens fruit functions as the minister ingredient; the Phellodendron amurense bark extract functions as the assistant ingredient; and the Foeniculum vulgare seed extract functions as the servant ingredient. Preferably, this blend of fermented plant extract further comprises one or more additional minister ingredients selected from the group consisting of fermented extracts from Santalum album stem, Hordeum distichon seed, and Citrus reticulata peel, and most preferably, it comprises all three additional minister ingredients.
  • The fermented extract of Rhodiola rosea rhizome is preferably present in this blend at an amount ranging from about 10% to about 50%, more preferably from about 15% to about 45%, and most preferably from about 25% to about 30%, by total weight of the blend. The fermented extract of Perilla frutescens fruit is preferably present in this blend at an amount ranging from about 0.5% to about 30%, more preferably from about 1% to about 20%, and most preferably from about 5% to about 15%, by total weight of the blend. The fermented extract of Phellodendron amurense bark is preferably present in this blend at an amount ranging from about 0.5% to about 30%, more preferably from about 1% to about 20%, and most preferably from about 5% to about 15%, by total weight of the blend. The fermented extract of Foeniculum vulgare seed is preferably present in this blend at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 2% to about 5%, by total weight of the blend. If present, the fermented extract of Santalum album stem is preferably at an amount ranging from about 0.1% to about 15%, more preferably from about 1% to about 10%, and most preferably from about 2% to about 5%, by total weight of the blend. If present, the fermented extract of Hordeum distichon seed is preferably at an amount ranging from about 10% to about 50%, more preferably from about 15% to about 45%, and most preferably from about 25% to about 30%, by total weight of the blend. If present, the Citrus reticulata peel is preferably at an amount ranging from about 5% to about 40%, more preferably from about 10% to about 30%, and most preferably from about 15% to about 20%, by total weight of the blend. This blend of fermented plant extracts is used to balance both the Yin-dominant skin composition and the balanced-to-Yin skin composition, but at different concentrations. For example, the concentrations of fermented plant extracts in products designated for the balanced-to-Yin skin composition are preferably from 25% to 75%, more preferably from about 40% to about 60%, of those in products designated for the Yin-dominant skin composition.
  • The present invention further provides a blend of fermented plant extracts for treating dark circles, puffiness, and wrinkles around the periorbital areas. According to TCM theories, dark circles are caused by stasis of Qi and body fluid, while puffiness around the eye area is caused by dampness and stasis of body fluid. Therefore, the present invention provides a blend of fermented plant extracts containing four ingredients for complementing Qi, improving the circulation of body fluid, removing dampness, tightening the skin, and prevent pre-mature skin aging. Such a blend contains fermented extracts from Ligusticum chuangxiong root, Paeonia lactiflora root, Rehmannia glutinosa root, and Zizyphus jujube fruit. The Ligusticum chuangxiong root extract functions as the emperor or king ingredient in this blend; the Paeonia lactiflora root functions as the minister ingredient; the Rehmannia glutinosa root extract functions as the assistant ingredient; and the Zizyphus jujube fruit extract functions as the servant ingredient. The fermented extract of Ligusticum chuangxiong root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend. The fermented extract of Paeonia lactiflora root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend. The fermented extract of Rehmannia glutinosa root is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend. The fermented extract of Zizyphus jujube fruit is preferably present in this blend at an amount ranging from about 5% to about 50%, more preferably from about 10% to about 40%, and most preferably from about 20% to about 30%, by total weight of the blend.
  • The above-described blends of plant extracts can further include other plant extracts of known skin care benefit but are not specifically mentioned herein. Such plant extracts may include, but are not limited to, those obtained from roots, leaves, flowers, stalks or other parts of plants such as Simmondsia Chinensis, Camellia Sinensis, Coffee Arabica, Betula Alba, Zea Mays, Siegesbeckia Orientalis, Helianthus Annus, Hordeum Vulgare, Cucumis Sativus, Carthamus Tinctorius, Mangifera Indicia, Garcinia Indica, Anthemus Nobilis, Arabidopsis Thaliana, Myrtus Communis, Apium Graveolens (Celery), Arabidopsis Thaliana, Padina Pavonica, Beta Vulgaris, Betula Alba, Butyrosperum Parkii, Garcinia Mangostana, Racemusus, Platycodon, Emblica Officinalis, Criste Marine, Lavande Papillon, Polygonum Cuspidatum, Laminaria Japonica, Fucus Vesiculosis, Borago Officinalis, Phyllanthus Emblica, Inonotus Obliquus, Calophyllum Inophyllum, Scutellaria Baicalensi), Boswellia Serrata, Boswellia Bhaudajiana, Boswellia Frereana, Boswellia Papyrifera, Sudanese Boswellia Sacra, Boswellia Carteri, Commiphora Incisa, Commiphora Myrrha, Commiphora Abyssinica, Commiphora Erthraea, Commiphora Molmol, Bursera Microphylla; Nidularium Procerumt, Curcuma Longa, Macrycystis Pyrifera, Pleurotus Ostreatus, Hypsizygus Ulmarius, Cladosiphon Okamuranus, Acalypha Wilkesiana, Acanthopanax Gracilistylus, Allium Sativum, Ananus Comosus, Cissampelos Sympodialis, Coriolus Versicolor, Echinacea Purpurea, Grifola Frondosa, Harpagophytum Procumbens, Panax Ginseng, Polygala Tenuifolia, Poria Cocos, Silybum Marianum, Smilax Glabra, Tinospora Cordifolia, Uncaria Tomentosa, Withania Somnifera, Echinancea, Viscum Album, Capparis Moonii, Capsella Brusa Pastoris, Doliocarpus Verruculosus, Kaempferia Galanga, Sauropus Androgynus, Tetracapidium Conophorum, Pinus Pinaster, Vitis Vinefera, Pluchea Indica, Viola Hondoensis, Triphala Chebula, Citri Reticulatae, Tepescohuite, Mimosa Pudica, Silymarin, Eucommia, Menyanthes Trifoliata, Calluna Vulgaris, Rosa Canina, Polyporus Umbellatus, Chamomilla Recutita, Pygeum Africanum, Actina Boswellia, Soft Pygeurm Capsicum Annum, Carpinus Laxiflora, Parinus Tschonoskii, Castanopsis Cuspidata, Selaginella Tamariscina, Rosmarinus Officinalis, Cayaponia Tayuya, Celosia, Cristata, Cercis Chinensis, Haplophyllum hispanicum, Scutellaria Rivularis, Centauriumt, Polygonum Cuspidatum, Nigella Sativa, Rhodiola Rosea, Anemarrhena asphodeloides, Zhi Mu, Uncaria Tomentosa Cereus Granidflora, Chaenomeles Sinensis, Lyngbya, Viapure Poria, Polyporus Umbellatus, Chrysanthellum Indicum, Tridentata marginate, Paeonia Alb flora, Saussurea Costus, Saussurea Lappa, Magnolia Officianalis, Echineacea Pallida and those set forth on pages 2755-2757 of the C.T.F.A. International Cosmetic Ingredient Dictionary and Handbook, Eleventh Edition, 2006, which is hereby incorporated by reference in its entirety.
  • Particularly, extracts from certain fungi with known medicinal benefits can be included in the blends of plant extracts of the present invention. For example, fungi from the genus Trametes are known for their medicinal properties. Sophisticated outdoorsmen will sometimes chew a piece of fungi picked from Trametes Versicolor (also referred to as Turkey Tail) like gum when they are hiking in the woods. It has been discovered by the inventors that in addition to their known medicinal properties, Trametes extracts also have beneficial properties when applied to the skin. Specifically, Trametes extracts contain certain chemical components that are particularly effective in whitening or brightening the skin. It is believed that such skin-whitening or brightening effect is achieved either through inhibition of tyrosinase activity or other cellular pathways that lead to skin pigmentation, thereby preventing formation of age spots or mottled skin, or through destruction of melanin in already formed age spots or mottled skin and thereby improving the overall evenness of the skin tone. Extracts from the Trametes genus are also excellent moisturizers, and some species may also be useful in absorbing excess sebum in oily skinned individuals.
  • Various plants or raw plant materials as described hereinabove are first cut and cleaned and then subjected to a low temperature water extraction process, in which the plant materials are immersed in a solvent system consisting essentially of deionized water at a temperature ranging from about 75° C. to about 95° C. (preferably from about 80° C. to about 90° C.) and a pressure ranging from about 0.03 to about 0.05 mpa for a duration of about 8 to 10 hours. The extraction solution is then concentrated at a temperature ranging from about 50° C. to about 65° C. (preferably from about 55° C. to about 60° C.) and under a vacuum condition characterized by a negative pressure ranging from about 1 torr to about 100 torr, more preferably from about 5 torr to about 50 torr, and most preferably about 10-15 ton. The concentrated extract solution is then spray dried at a temperature ranging from about 100° C. to about 150° C., preferably 120° C. to about 140° C., to form fine powders ready for packaging and shipping.
  • The blends of plant extracts in the above-described fine powder form can be directly formulated into topical or cosmetic compositions. However, such topical or cosmetic compositions are typically characterized by a distinctive bitter odor and a brownish dark color commonly associated with TCM extracts and may not be considered aesthically and olfactorily acceptable by most users of cosmetic or skin care products. In order to improve the aesthetic and olfactory appeal of the final cosmetic or skin care products, the present invention employs a unique fermentation process to further treat the blends of plant extracts as described hereinabove.
  • The fermentation process of the present invention comprises incubating a blend of plant extracts in the presence of yeast, fungi, or other suitable aerobically metabolizing microorganisms, under suitable aerobic conditions, for a period of time sufficient to reduce or eliminate the undesirable odor and/or color of the plant extracts while preserving the desirable biological activities of the TCM ingredients. In a particularly preferred embodiment, the microorganism used for fermenting the plant extracts is a fungus from the genus Trametes, and more preferably from the species Trametes Versicolor.
  • The fermentation process can take either one of two approaches. The first approach is a process in which the microorganism is fermented not only in the presence of the plant extracts but also with traditional culturing nutrients. During such incubation, the yeast or other microorganisms can multiply significantly in number. The second, and preferred, approach is to ferment the yeast or other microorganisms in an aqueous environment, in the presence of only the plant extracts and in substantial absence of any additional nutrients, or in a low nutrient media, so that during the fermentation process, the yeast or other microorganisms only engage in catabolic processing of the plant extracts. The incubation is monitored periodically for signs of the plateauing of biological activity, for example, a leveling off of pH, and then the system temperature is raised to between about 30-50° C., preferable about 40-45° C., for at least about 24 hours. In one embodiment, the temperature is then briefly raised to 90-95° C. for a period of about 5-10 minutes, which ruptures the yeast, releasing the cell contents. Alternately, the cells can be disrupted by sonication. The entire system is then cooled to room temperature, and filtered with progressively decreasing pore size to remove yeast debris, leaving a fermented extract that has significantly reduced odor and/or color in comparison with the unprocessed extract.
  • The amount of plant extracts used is also not critical; however, if it is desired to prevent proliferation of the yeast or other microorganisms, the amount should be controlled so as not to provide enough nutrients so to allow multiplication. Ordinarily, the amount of plant extracts used in the incubation medium of the present invention ranges from about 0.01 to about 10%, preferably from about 0.01 to about 5%, by total weight of the incubation medium, the concentration depending on the types of plant extracts used as well as on the solubility thereof.
  • In one embodiment of the invention as described above, the incubation medium contains simply water in addition to the plant extracts. In a preferred embodiment, the water used, however, is a structured water, i.e., I water, S water, or a combination of the two, as described, for example, in RO 88053 [S-type water], and RO 88054 (1-type water], and U.S. Pat. Nos. 5,846,397 and 6,139,855, the contents of which are incorporated herein by reference. The use of structured water in one or both of these phases of the fermentation process can further enhance the desired biological activities of the plant extracts. As also noted above, the incubation medium is generally not supplied with any other nutrients besides the plant extracts, so that the sole source of substrate for the microorganisms' biochemical activity is the plant extracts provided. However, in an alternate embodiment, the fermentation process can be performed in the presence of a nutrient medium appropriate for the growth of the microorganisms.
  • The fermentation process as described hereinabove not only functions to reduce or eliminate the undesirable odor and color typically associated with TCM ingredients, but is also capable of enhancing or boosting the desired biological activities of the TCM ingredients. Such desired biological activities include, but are not limited to: ATP-elevating activities, anti-inflammation activities, anti-irritation activities, immune modulating activities, blood circulation-enhancing activities, anti-oxidant activities, photoprotective activities, anti-histamine activities, skin-whitening activities, anti-chemotactic activities, collagen synthesis-enhancing activities, fibronectin synthesis-enhancing activities, anti-glycation activities, anti-phospholipase A2 (PLA2) activities, phosphodiesterase (PDE)-inhibiting activities, superoxide dismutase (SOD)-like activities, DNA synthesis-enhancing activities, protein synthesis-enhancing activities, DNA-repairing activities, skin barrier-repairing activities, anti-glycosaminoglycanase activities, anti-elastase activities, catalase-like activities, interleukin-1 (IL-1) alpha protein-inhibiting activities, interleukin-8 (IL-8) protein-inhibiting activities, prostaglandin E2 (PGE2)-inhibiting activities, cyclooxygenase-2 (COX-2)-inhibiting activities, anti-tyrosinase activities, anti-adhesion activities, 5-lipoxygenase (5-LO)-inhibiting activities, and the like.
  • The fermented blends of plant extracts as described hereinabove can be used for formulating various cosmetic and skin care compositions of various forms, such as anhydrous or aqueous gels, solutions or serums, emulsions (such as water-in-oil, oil-in-water, water-in-silicone, or silicone-in-water emulsions). Suggested amount of the fermented plant extracts as used in such compositions may range from about 0.001% to about 75%, preferably from about 0.05% to about 70%, more preferably from about 0.1% to about 65%. If in anhydrous form, the composition generally comprises from about 0.1-95% oil, and optionally other ingredients such as powders, sunscreens, and the like, with all percentages meaning percent by weight unless otherwise indicated. If in aqueous gel, solution, or serum form, the composition may comprise from about 1-99% water, and optionally other ingredients. If in emulsion form, the composition may comprise from about 0.1% to about 99%, preferably from about 5% to about 95%, more preferably from about 7% to about 90% water and from about 0.1% to 99%, preferably from about 5% to about 95%, more preferably from about 7% to about 90% oil or silicone.
  • Types of cosmetic or skin care compositions that the present invention covers include, but are not limited to: mascara, blush, eye shadow, eyeliner, skin cream, skin lotion, skin treatment serum, foundation, lipstick, lip gloss, and the like. Such compositions may include various cosmetic or skin care ingredients, as described hereinafter:
  • 1. Oils
  • The cosmetic or skin care compositions of the present invention may contain one or more oils which may be volatile or non-volatile. The term “oil” refers to an ingredient that is pourable at room temperature (e.g. 25° C.) The term “volatile” means that the oil has a vapor pressure of greater than about 2 mm. of mercury at 20° C. Volatile oils may include silicones or paraffinic hydrocarbons. If present, such volatile oils may range from about 0.1 to 50%. Examples of volatile silicones include linear silicones such as hexamethyldisiloxane (0.5 centistokes (cs)), octamethyltrisiloxane (1.0 cs), decamethyltetrasiloxane (1.5 cs), dodecamethylpentasiloxane (2.0 cs); or cyclic volatile silicones generally referred to as “cyclomethicone”, which may be octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, and so on. Examples of volatile paraffinic hydrocarbons include isohexadecane, isododecane, C9-11 isoparaffins, and the like.
  • Nonvolatile oils may include silicones, hydrocarbons, or esters. The term “nonvolatile” means that the oil has a vapor pressure of less than about 2 mm. of mercury at 20° C. Examples of nonvolatile silicones include dimethicone or diethicone; phenyl-substituted silicones such as phenyl trimethicone, diphenyl dimethicone, phenyl dimethicone, trimethylsiloxyphenyl dimethicone, phenethyl dimethicone; and the like; C2-14 alkyl substituted silicones such as cetyl dimethicone, hexyl dimethicone, lauryl dimethicone; or fluorinated silicones such as perfluorononyl dimethicone, trifluoropropyl dimethicone; and the like.
  • Examples of non-volatile hydrocarbons include hydrocarbons having from 10 to 40 carbon atoms in the linear or branched form such as C10-40 isoparaffins, C12-20 isoparaffins; or olefins having from about 18 to 54 carbon atoms, for example C18-26 olefin, C20-24 olefin, C26-54 olefin; polybutene, polyisobutene, polydecene, or hydrogenated derivatives thereof such as hydrogenated polyisobutene; isoeicosane; squalane; squalene; and so on.
  • Examples of esters include those formed by the reaction of mono-, di-, or polyhydric C1-10 alcohols with carboxylic acids having from about 1 to 40 carbon atoms, preferably fatty C6-22 carboxylic acids. Preferred alcohols include ethanol, propanol, butanol, hexanol, glycerin, and so on. Preferred carboxylic acids include myristic, stearic, isostearic, palmitic, behenic, and so on. One particularly preferred ester is formed by the reaction of a polyhydric alcohol with fatty carboxylic acids, more specification glycerin and stearic acid, to provide glyceryl stearate, diglyceryl diisostearate, glyceryl triisostearate, and so on. Most preferred is glyceryl stearate.
  • 2. Film Formers
  • The cosmetic or skin care compositions of the present invention may comprise at least one film former which is capable of forming a film when applied to the skin surface. If present, suggested ranges of film former(s) are from about 0.1 to 45%, preferably from about 0.5 to 40%, more preferably from about 0.5 to 30%. Film formers may be synthetic or natural polymers. They may be water soluble or oil soluble. They may be in the form of particles in aqueous dispersion, or solubilized or dispersed in the lipophilic phase of the composition. Examples of film forming polymers include polyurethanes either in lipophilic form or in the form of particles in aqueous dispersion; copolymers from ethylenically unsaturated monomers, for example, homo- or copolymers of acrylates, ammonium acrylates, styrene, acrylamides, methacrylates, vinyl acetate, vinyl pyrrolidone; or siloxy silicate polymers such as trimethylsiloxysilicate, polymethylsilsesquioxane; or silicone gums which are general dimethicone or dimethiconol having a degree of polymerization ranging from about 100,000 to 100 million cs. Examples of such film forming polymers include, but are not limited to, acrylates copolymer, polyurethane, acrylamide/ammonium acrylate copolymer, acrylamides copolymer, acrylates/acrylamide copolymer, acrylates/ammonium methacrylate copolymer, acrylates/octylacrylamide copolymer, PVP, PVA, PVP/VA copolymer, acrylates/VA copolymer, acrylates/VP copolymer, ammonium styrene/acrylates copolymer, and so on. Also suitable are naturally occurring polymers such as shellac or cellulose. Preferred is where the film former is shellac in aqueous dispersion which comprises from about 10-70% water, 1-40% shellac, and optionally from about 0.1-40% of a monohydric alcohol (preferably isopropanol or ethanol) and from about 0.0001 to 10% of a neutralizer which may be ammonium hydroxide. Also preferred is where the film former comprises a vinyl pyrrolidone homo- or copolymer such as PVP, PVP/VA copolymer and so on.
  • 3. Structuring Agents
  • The cosmetic or skin care compositions of the present invention may also contain at least one structuring agent which increases the viscosity or thickens the composition. If present, suggested ranges of structuring agent(s) are from about 0.1-70%, preferably from about 0.5-65%, more preferably from about 1-60%. Structuring agents may be natural or synthetic waxes, polymeric materials that increase viscosity, and the like. Examples of waxes include polyethylene, polypropylene, beeswax, beeswax modified by reacting with polyethylene glycol, such as PEG-8 beeswax, PEG-10 beeswax, carnauba, ceresin, microcrystalline, or fatty alcohols such as stearyl, behenyl; or fatty acids such as stearic acid, behenic acid, isostearic acid, and so on. Also suitable as structuring agents are polyamides or silicone polyamides. Examples include those sold by Arizona Chemical under the trademarks Sylvaclear® and Uniclear®, including those having the INCI names ethylenediamine/stearyl dimer tallate copolymer or ethylenediamine/stearyl dimer dilinolate copolymer, ethylenediamine/dimer tallate copolymer bis-hydrogenated tallow amide; Polyamide-3; ethylenediamine/hydrogenated dimer dilinoleate copolymer bis-di-C14-18 alkyl amide; Polyamide-4; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer and the like. Silicone waxes may also be used including but not limited to stearyl dimethicone, behenyl dimethicone, behenoxy dimethicone, stearoxy dimethicone, and so on. Also suitable as structuring agents are N-acyl amino acids or esters or amides thereof; 12-hydroxystearic acid or esters or amides thereof; fatty acid esters of di- or trifunctional alcohol dimers; or alkylamides of di- or tricarboxylic acids. Examples include stearamide MEA-stearate, N-acyl glutamic acid diamide, and so on.
  • Also suitable as structuring agents are naturally occurring ingredients that increase viscosity such as gums, including but not limited to Acacia Senegal gum, Veegum (magnesium aluminum silicate), biosaccharide gum, Boswellia Serrata gum, Cassia gum, cellulose gum, Gellan gum, xanthan gum, algin, agarose, cellulose, hydroxyethylcellulose, and the like.
  • Silicone elastomers are also suitable structuring agents and include those that are formed by addition reaction-curing, by reacting an SiH-containing diorganosiloxane and an organopolysiloxane having terminal olefinic unsaturation, or an alpha-omega diene hydrocarbon, in the presence of a platinum metal catalyst.
  • Examples of suitable silicone elastomers for use in the compositions of the invention may be in the powder form, or dispersed or solubilized in solvents such as volatile or non-volatile silicones, or silicone compatible vehicles such as paraffinic hydrocarbons or esters. Examples of silicone elastomer powders include vinyl dimethicone/methicone silsesquioxane crosspolymers like Shin-Etsu's KSP-100, KSP-101, KSP-102, KSP-103, KSP-104, KSP-105, hybrid silicone powders that contain a fluoroalkyl group like Shin-Etsu's KSP-200 which is a fluoro-silicone elastomer, and hybrid silicone powders that contain a phenyl group such as Shin-Etsu's KSP-300, which is a phenyl substituted silicone elastomer; and Dow Corning's DC 9506. Examples of silicone elastomer powders dispersed in a silicone compatible vehicle include dimethicone/vinyl dimethicone crosspolymers supplied by a variety of suppliers including Dow Corning Corporation under the tradenames 9040 or 9041, GE Silicones under the tradename SFE 839, or Shin-Etsu Silicones under the tradenames KSG-15, 16, 18. KSG-15 has the CTFA name cyclopentasiloxane/dimethicone/vinyl dimethicone crosspolymer. KSG-18 has the INCI name phenyl trimethicone/dimethicone/phenyl vinyl dimethicone crosspolymer. Silicone elastomers may also be purchased from Grant Industries under the Gransil trademark. Also suitable are silicone elastomers having long chain alkyl substitutions such as lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu under the tradenames KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44. Cross-linked organopolysiloxane elastomers useful in the present invention and processes for making them are further described in U.S. Pat. No. 4,970,252 to Sakuta et al., issued Nov. 13, 1990; U.S. Pat. No. 5,760,116 to Kilgour et al., issued Jun. 2, 1998; U.S. Pat. No. 5,654,362 to Schulz, Jr. et al. issued Aug. 5, 1997; and Japanese Patent Application JP 61-18708, assigned to Pola Kasei Kogyo K K, each of which are herein incorporated by reference in its entirety.
  • The cosmetic or skin care compositions of the present invention may also contain one or more aqueous phase thickeners. If present, suggested ranges are from about 0.1-30%, preferably from about 0.5-25%, more preferably from about 0.5-20%. Suitable thickeners include acrylic polymeric thickeners comprised of monomers of acrylic acid, methacrylic acid, or their simple C1-22 alkyl esters. Acrylic polymer solutions include those sold by Seppic, Inc., under the tradename Capigel having the CTFA name Acrylates Copolymer.
  • Also suitable are acrylic polymeric thickeners that are copolymers of acrylic acid, methacrylic acid or their C1-22 alkyl esters further copolymerized with one or more fatty alkoxylated alcohols. Examples of such thickening agents include acrylates/steareth-20 methacrylate copolymer, which is sold by Rohm & Haas under the tradename Acculyn 22, or acrylates/steareth-20/methacrylate crosspolymer which may be purchased from Rohm & Haas under the tradename Acculyn 88.
  • Also suitable are acrylate based anionic amphiphilic polymers containing at least one hydrophilic unit and at least one allyl ether unit containing a fatty chain. Preferred are those where the hydrophilic unit contains an ethylenically unsaturated anionic monomer, more specifically a vinyl carboxylic acid such as acrylic acid, methacrylic acid or mixtures thereof, and where the allyl ether unit containing a fatty chain corresponds to the monomer of formula:

  • CH2═CR′CH2OBnR
  • in which R′ denotes H or CH3, B denotes the ethyleneoxy radical, n is zero or an integer ranging from 1 to 100, R denotes a hydrocarbon radical selected from alkyl, arylalkyl, aryl, alkylaryl and cycloalkyl radicals which contain from 8 to 30 carbon atoms, preferably from 10 to 24, and even more particularly from 12 to 18 carbon atoms. More preferred in this case is where R′ denotes H, n is equal to 10 and R denotes a stearyl (C18) radical. Anionic amphiphilic polymers of this type are described and prepared in U.S. Pat. Nos. 4,677,152 and 4,702,844, both of which are hereby incorporated by reference in their entirety. Among these anionic amphiphilic polymers, polymers formed of 20 to 60% by weight acrylic acid and/or methacrylic acid, of 5 to 60% by weight lower alkyl methacrylates, of 2 to 50% by weight allyl ether containing a fatty chain as mentioned above, and of 0 to 1% by weight of a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, for instance diallyl phthalate, allyl (meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate and methylenebisacrylamide. One commercial example of such polymers are crosslinked terpolymers of methacrylic acid, of ethyl acrylate, of polyethylene glycol (having 10 EO units) ether of stearyl alcohol or steareth-10, in particular those sold by the company Allied Colloids under the names SALCARE SC80 and SALCARE SC90, which are aqueous emulsions containing 30% of a crosslinked terpolymer of methacrylic acid, of ethyl acrylate and of steareth-10 alkyl ether (40/50/10).
  • Also suitable are acrylate copolymers such as Polyacrylate-3 which is a copolymer of methacrylic acid, methylmethacrylate, methylstyrene isopropylisocyanate, and PEG-40 behenate monomers; Polyacrylate-10 which is a copolymer of sodium acryloyldimethyltaurate, sodium acrylate, acrylamide and vinyl pyrrolidone monomers; or Polyacrylate-11, which is a copolymer of sodium acryloyldimethylacryloyldimethyl taurate, sodium acrylate, hydroxyethyl acrylate, lauryl acrylate, butyl acrylate, and acrylamide monomers.
  • Also suitable are crosslinked acrylate based polymers where one or more of the acrylic groups may have substituted long chain alkyl (such as 6-40, 10-30, and the like) groups, for example acrylates/C10-30 alkyl acrylate crosspolymer which is a copolymer of C10-30 alkyl acrylate and one or more monomers of acrylic acid, methacrylic acid, or one of their simple esters crosslinked with the allyl ether of sucrose or the allyl ether of pentaerythritol. Such polymers are commonly sold under the Carbopol or Pemulen tradenames.
  • Particularly suitable as the aqueous phase thickening agent are acrylate based polymeric thickeners sold by Clariant under the Aristoflex trademark such as Aristoflex AVC, which is ammonium acryloyldimethyltaurate/VP copolymer; Aristoflex AVL which is the same polymer has found in AVC dispersed in mixture containing caprylic/capric triglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate; or Aristoflex HMB which is ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer, and the like.
  • Also suitable as the aqueous phase thickening agents are various polyethylene glycols (PEG) derivatives where the degree of polymerization ranges from 1,000 to 200,000. Such ingredients are indicated by the designation “PEG” followed by the degree of polymerization in thousands, such as PEG-45M, which means PEG having 45,000 repeating ethylene oxide units. Examples of suitable PEG derivatives include PEG 2M, 5M, 7M, 9M, 14M, 20M, 23M, 25M, 45M, 65M, 90M, 115M, 160M, 180M, and the like.
  • Also suitable are polyglycerins which are repeating glycerin moieties where the number of repeating moieties ranges from 15 to 200, preferably from about 20-100. Examples of suitable polyglycerins include those having the CFTA names polyglycerin-20, polyglycerin-40, and the like.
  • Also suitable as aqueous phase thickening agents are various types of polysaccharides, such as xanthan gum, cellulose, dextrin, cyclodextrin, hydroxyethylcellulose, acacia gum, and the like.
  • 4. Emulsifiers
  • The cosmetic or skin care compositions of the present invention may further comprise at least one emulsifier or surfactant. If present, suggested ranges of such emulsifier(s) or surfactant(s) are from about 0.01-40%, preferably from about 0.05-35%, more preferably from about 0.1-25%. Suitable emulsifiers may be silicone based emulsifiers or surfactants including linear or crosslinked polyoxyalkylene substituted organosiloxanes or alkyl substituted polyoxyalkylene organosiloxanes. Examples include those having the generic name dimethicone copolyol, cetyl dimethicone copolyol, and so on. Examples of silicone surfactants are those sold by Dow Corning under the tradename Dow Corning 3225C Formulation Aid having the CTFA name cyclotetrasiloxane (and) cyclopentasiloxane (and) PEG/PPG-18 dimethicone; or 5225C Formulation Aid, having the CTFA name cyclopentasiloxane (and) PEG/PPG-18/18 dimethicone; or Dow Corning 190 Surfactant having the CTFA name PEG/PPG-18/18 dimethicone; or Dow Corning 193 Fluid, Dow Corning 5200 having the CTFA name lauryl PEG/PPG-18/18 methicone; or Abil EM 90 having the CTFA name cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil EM 97 having the CTFA name bis-cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil WE 09 having the CTFA name cetyl PEG/PPG-10/1 dimethicone in a mixture also containing polyglyceryl-4 isostearate and hexyl laurate; or KF-6011 sold by Shin-Etsu Silicones having the CTFA name PEG-11 methyl ether dimethicone; KF-6012 sold by Shin-Etsu Silicones having the CTFA name PEG/PPG-20/22 butyl ether dimethicone; or KF-6013 sold by Shin-Etsu Silicones having the CTFA name PEG-9 dimethicone; or KF-6015 sold by Shin-Etsu Silicones having the CTFA name PEG-3 dimethicone; or KF-6016 sold by Shin-Etsu Silicones having the CTFA name PEG-9 methyl ether dimethicone; or KF-6017 sold by Shin-Etsu Silicones having the CTFA name PEG-10 dimethicone; or KF-6038 sold by Shin-Etsu Silicones having the CTFA name lauryl PEG-9 polydimethylsiloxyethyl dimethicone.
  • Also suitable are various types of crosslinked silicone surfactants that are often referred to as emulsifying elastomers. They are typically prepared as set forth above with respect to the section “silicone elastomers” except that the silicone elastomers will contain at least one hydrophilic moiety such as polyoxyalkylenated groups. Typically these polyoxyalkylenated silicone elastomers are crosslinked organopolysiloxanes that may be obtained by a crosslinking addition reaction of diorganopolysiloxane comprising at least one hydrogen bonded to silicon and of a polyoxyalkylene comprising at least two ethylenically unsaturated groups. In at least one embodiment, the polyoxyalkylenated crosslinked organo-polysiloxanes are obtained by a crosslinking addition reaction of a diorganopolysiloxane comprising at least two hydrogens each bonded to a silicon, and a polyoxyalkylene comprising at least two ethylenically unsaturated groups, optionally in the presence of a platinum catalyst, as described, for example, in U.S. Pat. No. 5,236,986 and U.S. Pat. No. 5,412,004, U.S. Pat. No. 5,837,793 and U.S. Pat. No. 5,811,487, the contents of which are incorporated by reference.
  • Polyoxyalkylenated silicone elastomers that may be used in at least one embodiment of the invention include those sold by Shin-Etsu Silicones under the names KSG-21, KSG-20, KSG-30, KSG-31, KSG-32, KSG-33; KSG-210 which is dimethicone/PEG-10/15 crosspolymer dispersed in dimethicone; KSG-310 which is PEG-15 lauryl dimethicone crosspolymer; KSG-320 which is PEG-15 lauryl dimethicone crosspolymer dispersed in isododecane; KSG-330 (the former dispersed in triethylhexanoin), KSG-340 which is a mixture of PEG-10 lauryl dimethicone crosspolymer and PEG-15 lauryl dimethicone crosspolymer.
  • Also suitable are polyglycerolated silicone elastomers like those disclosed in PCT/WO 2004/024798, which is hereby incorporated by reference in its entirety. Such elastomers include Shin-Etsu's KSG series, such as KSG-710 which is dimethicone/polyglycerin-3 crosspolymer dispersed in dimethicone; or lauryl dimethicone/polyglycerin-3 crosspolymer dispersed in a variety of solvent such as isododecane, dimethicone, triethylhexanoin, sold under the Shin-Etsu tradenames KSG-810, KSG-820, KSG-830, or KSG-840. Also suitable are silicones sold by Dow Corning under the tradenames 9010 and DC9011.
  • The composition may comprise one or more nonionic organic surfactants. Suitable nonionic surfactants include alkoxylated alcohols, or ethers, formed by the reaction of an alcohol with an alkylene oxide, usually ethylene or propylene oxide. Preferably the alcohol is either a fatty alcohol having 6 to 30 carbon atoms. Examples of such ingredients include Steareth 2-100, which is formed by the reaction of stearyl alcohol and ethylene oxide and the number of ethylene oxide units ranges from 2 to 100; Beheneth 5-30 which is formed by the reaction of behenyl alcohol and ethylene oxide where the number of repeating ethylene oxide units is 5 to 30; Ceteareth 2-100, formed by the reaction of a mixture of cetyl and stearyl alcohol with ethylene oxide, where the number of repeating ethylene oxide units in the molecule is 2 to 100; Ceteth 1-45 which is formed by the reaction of cetyl alcohol and ethylene oxide, and the number of repeating ethylene oxide units is 1 to 45, and so on.
  • Other alkoxylated alcohols are formed by the reaction of fatty acids and mono-, di- or polyhydric alcohols with an alkylene oxide. For example, the reaction products of C6-30 fatty carboxylic acids and polyhydric alcohols which are monosaccharides such as glucose, galactose, methyl glucose, and the like, with an alkoxylated alcohol. Examples include polymeric alkylene glycols reacted with glyceryl fatty acid esters such as PEG glyceryl oleates, PEG glyceryl stearate; or PEG polyhydroxyalkanoates such as PEG dipolyhydroxystearate wherein the number of repeating ethylene glycol units ranges from 3 to 1000. Also suitable are ethoxylated propoxylated derivatives of C6-30 saturated or unsaturated fatty acids, for example, Di-PPG-2 myreth-10 adipate, Di-PPG-2 Ceteth-4 adipate, Di-PPG Myristyl Ether Adipate,
  • Also suitable as nonionic surfactants are formed by the reaction of a carboxylic acid with an alkylene oxide or with a polymeric ether. The resulting products have the general formula: where RCO is the carboxylic ester radical, X is hydrogen or lower alkyl, and n is the number of polymerized alkoxy groups. In the case of the diesters, the two RCO-groups do not need to be identical. Preferably, R is a C6-30 straight or branched chain, saturated or unsaturated alkyl, and n is from 1-100.
  • Monomeric, homopolymeric, or block copolymeric ethers are also suitable as nonionic surfactants. Typically, such ethers are formed by the polymerization of monomeric alkylene oxides, generally ethylene or propylene oxide. Such polymeric ethers have the following general formula: wherein R is H or lower alkyl and n is the number of repeating monomer units, and ranges from 1 to 500.
  • Other suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives. For example, alkoxylation, in particular ethoxylation of sorbitan provides polyalkoxylated sorbitan derivatives. Esterification of polyalkoxylated sorbitan provides sorbitan esters such as the polysorbates. For example, the polyalkoxylated sorbitan can be esterified with C6-30, preferably C12-22 fatty acids. Examples of such ingredients include Polysorbates 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and so on.
  • Most preferred for use in mascaras are organic emulsifiers that are the reaction product of polyethylene glycol with fatty acids, e.g. PEG1-200 with stearic, isostearic, myristic, behenic, cetearic, acids and so on. Particulately preferred is where the emulsifier comprises the reaction product of polyethylene glycol and stearic acid, e.g. PEG-100 stearate. Also suitable are derivatives of sorbitan such as Polysorbates; sorbitan esterified with stearic acid, e.g. sorbitan tristearate, and so on.
  • 5. Particulates
  • The cosmetic or skin care compositions may further comprise particulates, either in the from of pigments, powders or mixtures. Suitable pigments include inorganic pigments or iron oxides that are red, yellow, or black. Also suitable are organic pigments that are FD&C or D&C colors or Lakes thereof such as yellows, reds, blues, etc. Suitable powders include titanium dioxide, mica, bismuth oxychloride, titanated mica, PTFE, silica, bentonite, kaolin, talc, and the like. If present, suggested ranges of pigments are from about 0.01-45%, preferably from about 0.05-35%. Suggested ranges of powders are from about 0.01-10%.
  • 6. Humectants
  • The cosmetic or skin care compositions of the present invention may also contain one or more humectants. If present, suggested ranges of the humectant(s) are from about 0.1 to 25%. Humectants include glycols, sugars, and the like. Suitable glycols are in monomeric or polymeric form and include polyethylene and polypropylene glycols such as PEG 4-200, which are polyethylene glycols having from 4 to 200 repeating ethylene oxide units; as well as C1-6 alkylene glycols such as propylene glycol, butylene glycol, pentylene glycol, and the like. Suitable sugars, some of which are also polyhydric alcohols, are also suitable humectants. Examples of such sugars include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, trehalose, and so on. Also suitable is urea or sugar derivatives, e.g. ethylhexylglycerin. In one preferred embodiment, the humectants used in the composition of the invention are C1-6, preferably C2-4 alkylene glycols, most particularly butylene glycol.
  • The compositions may further contain other ingredients including but not limited to preservatives, sunscreens, and so on.
  • The invention will be further described in connection with the following examples which are set forth for purposes of illustration only.
  • Example 1
  • Fine powder containing a blend of plant extracts for maintaining and strengthening the Yin-Yang balance of a user with balanced skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Ingredient % by weight
    Cordyceps sinensis mycelia 24%
    Ginkgo biloba leaf 12%
    Polygonum cuspidatum rhizome 12%
    Citrus reticulata peel 12%
    Poria cocos sclerotium 24%
    Panax ginseng root 4%
    Perilla frutescens fruit 12%
    Total 100%
  • Example 2
  • Fine powder containing a blend of plant extracts for nourishing the Yin energy and balancing/neutralizing the excess Yang energy of a user with Yang-dominant skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Ingredient % by weight
    Ganoderma lucidum fruiting body 26.67%
    Selaginella tamariscina plant 13.33%
    Ginkgo biloba leaf 6.68%
    Calendula officinalis flower 13.33%
    Centella asiatica plant 13.33%
    Scutellaria baicalensis root 13.33%
    Polygonum cuspidatum rhizome 13.33%
    Total 100.00%
  • Example 3
  • Fine powder containing a blend of plant extracts for nourishing the Yang energy and balancing/neutralizing the excess Yin energy of a user with Yin-dominant skin composition was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Ingredient % by weight
    Rhodiola rosea rhizome 28.13%
    Perilla frutescens fruit 9.38%
    Phellodendron amurense bark 9.38%
    Foeniculum vulgare seed 3.13%
    Santalum album stem 3.13%
    Hordeum distichon seed 28.10%
    Citrus reticulata peel 18.75%
    Total 100.00%
  • Example 4
  • Fine powder containing a blend of plant extracts for treating dark circles, puffiness, and wrinkles around the eye areas of a user was prepared according to the extraction and drying techniques described hereinabove, which contains:
  • Ingredient % by weight
    Ligusticum chuanxiong root 25%
    Paeonia lactiflora root 25%
    Rehmannia glutinosa root 25%
    Zizyphus jujube fruit 25%
    Total 100%
  • Example 5
  • A sterilized cultural medium containing an aqueous solution of Difco malt extract broth at 1.5 wt % or 15 grams/liter was inoculated with Saccharomyces cerevisiae (baker's yeast) at about 24° C. for about 14 hours, until the yeast reached the end of log phase growth, to form an inoculum. Fine powder containing a blend of plant extracts as described hereinabove in Examples 1-4 was then added into a New Brunswick Scientific Bioflo 6000 reactor/fermentor of about 100 liters in volume, together with the inoculum and various ingredients described at below:
  • Ingredient % by weight
    De-ionized water QS
    Anti-foam 0.01%
    MEB 1.37%
    Inoculum 1.00%
    Powder containing TCM blend 0.92%
    Butylene glycol 4.58%
    Total 100.00%

    The mixture was incubated at about 24° C. and mixed at a speed of about 200 rpm for about 4 hours. The ferment solution was then sequentially passed through a 1% Celite Hyflo gel (diamateous earth), an Ertel 5-micron cellulose pad, a Cell Flow Hollow Fiber PES 0.2-micron tangential flow filter (Spectum Labs), and a SealKleen ultipore Nylon66 0.2-micron absolute dead-end filter (Pall Corporation).
  • Example 6
  • Colors of the blends of plant extracts as described hereinabove in Examples 1-4 before and after the fermentation process of Example 5 were compared using a LICO 100 color meter (Paul N. Gardner Company). Specifically, the samples were filled into 11 mm ground glass cavettes and then placed in the color meter, which provided an automatic reading of the colors in Gardner Color Number, as follows:
  • Color
    Before After
    Type of TCM Blend Fermentation Fermentation
    For Balanced Skin Composition 8.3 8.1
    For Yang-Dominate Skin Composition 6.1 5.5
    For Yin-Dominate Skin Composition 9.4 9.2
    For Eyes 6.0 5.6

    All samples showed reduction in color after fermentation, in comparison with the same samples before fermentation.
  • Example 7
  • Odors of the blends of plant extracts as described hereinabove in Examples 1-4 before and after the fermentation process of Example 5 were compared using an Alpha M.O.S. Fox electronic nose system. Specifically, a 1 mL aliquot of each sample was prepared in quadruplicate and ran on the electronic nose at about 45° C. and for about 250 or 450 seconds. The data obtained for each sample was plotted using the PSA model. In all cases, the PSA data showed observable difference between the TCM blends before fermentation and after fermentation. Further, smell tests conducted by human subjects confirmed a reduction of undesirable odor in TCM blends after fermentation, in comparison with the same blends before fermentation.
  • Example 8
  • Five (5) different types of skin care serums were formulated with the fermented TCM extracts described hereinabove for users with different skin compositions, including balanced (“B”), Yang (“Ya”), balanced-to-Yang (“B-Ya”), Yin (“Yi”), and balanced-to-Yin (“B-Yi”) skin compositions, respectively:
  • CONCENTRATION (WT %)
    INGREDIENTS B Ya B-Ya Yi B-Yi
    De-ionized water QS QS QS QS QS
    Cordyceps sinensis mycelia extract (fermented) 0.022
    Ginkgo biloba leaf extract (fermented) 0.011 0.006 0.004
    Polygonum cuspidatum rhizome extract 0.061 0.012 0.009
    (fermented)
    Citrus reticulata peel extract (fermented) 0.011 0.017 0.013
    Poria cocos sclerotium extract (fermented) 0.022
    Panax ginseng root extract (fermented) 0.004 0.200 0.200
    Perilla frutescens fruit extract (fermented) 0.041 0.008 0.006
    Ganoderma lucidum fruiting body extract 0.024 0.018
    (fermented)
    Selaginella tamariscina plant extract 0.012 0.009
    (fermented)
    Calendula officinalis flower extract (fermented) 0.012 0.009
    Centella asiatica plant extract (fermented) 0.012 0.009
    Scutellaria baicalensis root extract (fermented) 0.012 0.009
    Rhodiola rosea rhizome extract (fermented) 0.026 0.019
    Phellodendron amurense bark extract 0.008 0.006
    (fermented)
    Foeniculum vulgare seed extract (fermented) 0.003 0.002
    Santalum album stem extract (fermented) 0.003 0.002
    Hordeum distichon seed extract (fermented) 0.026 0.019
    Butylene glycol 4.458 4.649 5.534 4.465 5.350
    Neopentyl glycol diheptanoate 3.500 3.500 3.500 3.500 3.500
    Ethylhexyl isononanoate 3.000 3.000 3.000 2.500 2.500
    PEG-60 hydrogenated castor oil 1.800 1.800 1.800 1.800 1.800
    Pentylene glycol 1.000 1.000 1.000
    Cetyl ethylhexanoate 1.000 1.000 1.000 1.000 1.000
    Algae extract 0.980 0.980 0.980 0.980 0.980
    Saccharomyces/xylinum black tea extract 0.861 0.861 0.861 0.861 0.861
    Phenoxyethanol 0.744 0.749 0.445 0.756 0.455
    Caprylyl glycol 0.550 0.550 0.737 0.550 0.737
    Propylene glycol dicaprate 0.549 0.549 0.549 0.549 0.549
    Dimethicone 0.500 0.500 0.500
    Tromethamine 0.420 0.420 0.381 0.462 0.419
    Helianthus annuus (sunflower) seedcake 0.405 0.405 0.405 0.405 0.405
    Carbomer 0.400 0.400 0.400 0.440 0.440
    Polyglyceryl-2 sesquiisostearate 0.300 0.300 0.300 0.300 0.300
    Tocopheryl acetate 0.200 0.200 0.200 0.200 0.200
    Behenyl alcohol 0.200 0.200 0.200 0.100 0.100
    Malt extract 0.153 0.165 0.120 0.153 0.118
    Glycerin 0.120 0.120 0.120 0.120 0.120
    Disodium EDTA 0.100 0.100 0.050 0.104 0.054
    Inonotus obliquus (mushroom) extract 0.085 0.085 0.085 0.085 0.085
    Dextrin 0.070
    Potassium sorbate 0.051 0.051 0.051 0.051 0.051
    Xanthan gum 0.050 0.050 0.050
    Aminopropyl ascorbyl phosphate 0.050 0.050 0.050 0.050 0.050
    Citrus grandis (grapefruit) peel extract 0.050
    Hordeum vulgare (barley) extract 0.030 0.030 0.030 0.040 0.040
    Sodium hyaluronate 0.020 0.020 0.100 0.020 0.100
    Hydroxyethylcellulose 0.015 0.015 0.015 0.015 0.015
    Cellulose 0.015 0.015 0.015 0.015 0.015
    Adenosine phosphate 0.009 0.009 0.009 0.009 0.009
    Acetyl carnitine HCl 0.009 0.009 0.009 0.009 0.009
    Creatine 0.009 0.009 0.009 0.009 0.009
    Sodium citrate 0.009 0.009 0.009 0.009 0.009
    Cucumis sativus (cucumber) fruit extract 0.007 0.007 0.007 0.007 0.007
    Glycine soja (soybean) protein 0.005 0.005 0.005 0.005 0.005
    Citric acid 0.004 0.004 0.004 0.004 0.004
    Glycine 0.500 0.050
    Phytic acid 0.086 0.009
    Laminaria saccharina extract 0.005 0.005
    Oryza sativa (rice) bran extract 0.001
    Caffeine 0.200 0.200
    Sodium mannose phosphate 0.500 0.500
    Cholesterol 0.200 0.200
    Linoleic acid 0.200 0.200
    Squalane 0.118 0.118
    Sodium RNA 0.100 0.100
    Triticum vulgare (wheat) germ oil 0.050 0.050
    Helianthus annuus (sunflower) seed oil 0.020 0.020
    Sodium sulfite 0.004 0.004
    Sodium metabisulfite 0.004 0.004
    Sodium chloride 0.001 0.001
  • Example 9
  • Three (3) different types of watery lotions were formulated with the fermented TCM extracts described hereinabove for users with different skin compositions, including balanced (“B”), Yang (“Ya”), and Yin (“Yi”) skin compositions, respectively:
  • CONCEN-
    TRATIONS
    (WT %)
    INGREDIENTS B Ya Yi
    De-ionized water QS QS QS
    Cordyceps sinensis mycelia extract (fermented) 0.011
    Ginkgo biloba leaf extract (fermented) 0.005 0.003
    Polygonum cuspidatum rhizome extract (fermented) 0.010 0.006
    Citrus reticulata peel extract (fermented) 0.005 0.008
    Poria cocos sclerotium extract (fermented) 0.011
    Panax ginseng root extract (fermented) 0.002 0.200
    Perilla frutescens fruit extract (fermented) 0.006 0.005
    Ganoderma lucidum fruiting body extract 0.012
    (fermented)
    Selaginella tamariscina plant extract (fermented) 0.006
    Calendula officinalis flower extract (fermented) 0.006
    Centella asiatica plant extract (fermented) 0.006
    Scutellaria baicalensis root extract (fermented) 0.006
    Rhodiola rosea rhizome extract (fermented) 0.013
    Phellodendron amurense bark extract (fermented) 0.005
    Foeniculum vulgare seed extract (fermented) 0.001
    Santalum album stem extract (fermented) 0.001
    Hordeum distichon seed extract (fermented) 0.013
    Ethanol 6.000 6.000 6.000
    Butylene glycol 5.229 5.420 3.236
    Trehalose 1.400 1.400
    Glycerin 1.120 1.120 0.120
    Polysorbate 20 1.000 0.800 0.800
    Pentylene glycol 1.000 1.000 1.000
    Algae extract 0.980 0.980 0.980
    Saccharomyces/xylinum black tea extract 0.861 0.861 0.861
    Sodium citrate 0.550 0.100 0.106
    Phenoxyethanol 0.505 0.510 0.506
    Sodium mannose phosphate 0.500 0.500 0.500
    Citric acid 0.100 0.010 0.012
    Disodium EDTA 0.100 0.100 0.100
    Ethylhexylglycerin 0.100 0.100 0.100
    Xylitol 0.100 0.100
    Dipotassium glycyrrhizate 0.100 0.100 0.100
    Inonotus obliquus (mushroom) extract 0.085 0.085 0.085
    Malt extract 0.084 0.095 0.084
    Caprylyl glycol 0.025 0.025 0.025
    Sodium hyaluronate 0.020 0.020 0.020
    Hydroxyethylcellulose 0.015 0.015 0.015
    Cellulose 0.015 0.015 0.015
    Adenosine phosphate 0.009 0.009 0.009
    Creatine 0.009 0.009 0.009
    Acetyl carnitine HCl 0.009 0.009 0.009
    Glycine soja (soybean) protein 0.005 0.005 0.005
    Tocopheryl acetate 0.001 0.001 0.001
    Citrus grandis (grapefruit) peel extract 0.001
    Dextrin 0.001
    Propylene glycol dicaprate 0.001 0.001 0.001
    Glycine 0.500
    Phytic acid 0.086
    Laminaria saccharina extract 0.005
    Oryza sativa (rice) bran extract 0.001
    Dipropylene glycol 1.000
    Sodium RNA 0.100
    Sodium chloride 0.001
  • Example 10
  • An eye cream product was formulated with the fermented TCM extracts described hereinabove.
  • INGREDIENTS WT %
    De-ionized water QS
    Ligusticum chuanxiong root extract (fermented) 0.011
    Paeonia lactiflora root extract (fermented) 0.011
    Rehmannia glutinosa root extract (fermented) 0.011
    Zizyphus jujube fruit extract (fermented) 0.011
    Butyrospermum parkii (shea butter) 4.998
    Cetearyl alcohol 4.240
    Butylene glycol 4.229
    Hydrogenated polyisobutene 3.500
    Phenyl trimethicone 3.250
    Dimethicone 2.150
    Polybutene 2.000
    Polyglyceryl-3 beeswax 2.000
    Polymethyl methacrylate 1.724
    Isostearyl neopentanoate 1.500
    Cetearyl glycoside 1.060
    PEG-100 stearate 1.000
    Tocopheryl acetate 1.000
    Polysilicone-11 0.800
    Phenoxyethanol 0.632
    Propylene glycol dicaprate 0.549
    Stearic acid 0.500
    Helianthus annuus (sunflower) seedcake 0.405
    Squalane 0.375
    Glycerin 0.350
    Methyl glucose sesquistearate 0.350
    Ethylhexylglycerin 0.298
    Mica 0.294
    Caprylyl glycol 0.245
    Titanium dioxide 0.232
    Acrylates/C10-30 alkylacrylate crosspolymer 0.200
    Phytosphingosine 0.200
    Gentiana lutea (gentian) root extract 0.198
    Aminomethyl propanol 0.160
    Disodium EDTA 0.150
    Yeast extract 0.125
    Hordeum vulgare (barley) extract 0.105
    Xanthan gum 0.100
    Camellia sinensis (green tea) leaf extract 0.100
    Linoleic acid 0.100
    Salvia officinalis (sage) leaf extract 0.100
    Sodium dehydroacetate 0.100
    Sodium hyaluronate 0.100
    Magnesium ascorbyl phosphate 0.100
    Cholesterol 0.100
    Betula alba (birch) extract 0.100
    Malt extract 0.069
    Glycine soja (soybean) protein 0.050
    Triticum vulgare (wheat) germ extract 0.050
    Hexylene glycol 0.040
    Hydrogenated lecithin 0.010
    Cucumis sativus (cucumber) fruit extract 0.007
    Potassium sorbate 0.002
    BHT 0.001
    Tocopherol 0.001
  • While the invention has been described in connection with the preferred embodiment, it is not intended to limit the scope of the invention to the particular form set forth but, on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.

Claims (20)

1. A method for selecting a topical composition for a user based on his or her skin composition to improve the appearance or condition of the skin, comprising:
(a) collecting biological data from the user;
(b) categorizing the skin composition of the user based on the collected biological data, wherein said categorization is indicative of the Yin-Yang balance of the skin or the lack thereof; and
(c) selecting a topical composition for the user, wherein said topical composition contains a blend of fermented Chinese herbal extracts for maintaining or restoring the Yin-Yang balance of the skin.
2. The method of claim 1, wherein the biological data collected from the user comprises one or more types selected from the group consisting of age, bodily sensation, life style, sleep pattern, energy level, tongue color, tongue fur color, and skin condition.
3. The method of claim 1, wherein the skin composition of the user is categorized by using a statistical model that weights the biological data according to Traditional Chinese Medicinal (TCM) principles.
4. The method of claim 1, wherein the skin composition categories comprise balanced, Yang-dominant, and Yin-dominant.
5. The method of claim 4, wherein a first topical composition is selected if the user has a balanced skin composition, wherein said first topical composition comprises fermented extracts of Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel for maintaining and strengthening the Yin-Yang balance of the skin.
6. The method of claim 5, wherein the first topical composition further comprises one or more fermented extracts derived from Chinese herbs selected from the group consisting of Poria cocos sclerotium, Panax ginseng root, and Perilla frutescens fruit.
7. The method of claim 5, wherein a second topical composition is selected if the user has a Yang-dominant skin composition, wherein said second topical composition comprises fermented extracts of Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower for nourishing Yin and restoring the Yin-Yang balance of the skin.
8. The method of claim 7, wherein the second topical composition further comprises one or more fermented extracts derived from Chinese herbs selected from the group consisting of Centella asiatica plant, Scutellaria baicalensis root, and Polygonum cuspidatum rhizome.
9. The method of claim 7, wherein the skin composition categories further comprise a balanced-to-Yang category, wherein a third topical composition is selected if the user has the balanced-to-Yang category, and wherein said third topical composition comprises the same ferment Chinese herbal extracts as the second topical composition but at lower concentrations.
10. The method of claim 9, wherein a fourth topical composition is selected if the user has a Yin-dominant skin composition, wherein said fourth topical composition comprises fermented extracts of Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed for nourishing the Yang and restoring the Yin-Yang balance of the skin.
11. The method of claim 10, wherein the fourth topical composition further comprises one or more fermented extracts derived from Chinese herbs selected from the group consisting of Santalum album stem, Hordeum distichon seed, and Citrus reticulata peel.
12. The method of claim 10, wherein the skin composition categories further comprise a balanced-to-Yin category, wherein a fifth topical composition is selected if the user has the balanced-to-Yin skin composition, and wherein said fifth topical composition comprises the same ferment Chinese herbal extracts as the fourth topical composition but at lower concentrations.
13. A topical composition for application to the skin of a user with a balanced skin composition, comprising fermented extracts of Cordyceps sinensis mycelia, Ginkgo biloba leaf, Polygonum cuspidatum rhizome, and Citrus reticulata peel.
14. The topical composition of claim 13, further comprising one or more fermented extracts derived from Chinese herbs selected from the group consisting of Poria cocos sclerotium, Panax ginseng root, and Perilla frutescens fruit.
15. A topical composition for application to the skin of a user with a Yang-dominant or balanced-to-Yang skin composition, comprising fermented extracts of Ganoderma lucidum fruiting body, Selaginella tamariscina plant, Ginkgo biloba leaf, and Calendula officinalis flower.
16. The topical composition of claim 15, further comprising one or more fermented extracts derived from Chinese herbs selected from the group consisting of Centella asiatica plant, Scutellaria baicalensis root, and Polygonum cuspidatum rhizome.
17. A topical composition for application to the skin of a user with a Yin-dominant or balanced-to-Yin skin composition, comprising fermented extracts of Rhodiola rosea rhizome, Perilla frutescens fruit, Phellodendron amurense bark, and Foeniculum vulgare seed.
18. The topical composition of claim 17, further comprising one or more fermented extracts derived from Chinese herbs selected from the group consisting of Santalum album stem, Hordeum distichon seed, and Citrus reticulata peel.
19. A topical composition for application to the periorbital areas of a user, comprising fermented extracts of Ligusticum chuangxiong root, Paeonia lactiflora root, Rehmannia glutinosa root, and Zizyphus jujube fruit.
20. A method for preparing a topical composition, comprising fermenting a blend of extracts from one or more Traditional Chinese Medicinal (TCM) ingredients known to have undesirable odor and/or color in the presence of an aerobically metabolizing microorganism under suitable aerobic conditions for a period of time sufficient to reduce or eliminate the undesirable odor and/or color while preserving desirable biological activities of said TCM ingredients, and formulating the fermented blend of TCM extracts into a cosmetically or pharmaceutically acceptable carrier to form said topical composition.
US12/713,959 2009-03-11 2010-02-26 Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same Abandoned US20100233301A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US12/713,959 US20100233301A1 (en) 2009-03-11 2010-02-26 Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same
US13/270,529 US8580319B2 (en) 2009-03-11 2011-10-11 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US13/270,558 US20120270291A1 (en) 2009-03-11 2011-10-11 Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US14/043,021 US9327004B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,035 US9333231B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional methods of making and using same
US14/043,014 US9233134B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional Chinese medicinal (TCM) ingredients, and methods of making and using same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15927209P 2009-03-11 2009-03-11
US22899909P 2009-07-28 2009-07-28
US12/713,959 US20100233301A1 (en) 2009-03-11 2010-02-26 Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same

Related Child Applications (5)

Application Number Title Priority Date Filing Date
US13/270,558 Division US20120270291A1 (en) 2009-03-11 2011-10-11 Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US13/270,529 Division US8580319B2 (en) 2009-03-11 2011-10-11 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,014 Division US9233134B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional Chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,035 Division US9333231B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional methods of making and using same
US14/043,021 Division US9327004B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same

Publications (1)

Publication Number Publication Date
US20100233301A1 true US20100233301A1 (en) 2010-09-16

Family

ID=42729012

Family Applications (6)

Application Number Title Priority Date Filing Date
US12/713,959 Abandoned US20100233301A1 (en) 2009-03-11 2010-02-26 Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same
US13/270,558 Abandoned US20120270291A1 (en) 2009-03-11 2011-10-11 Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US13/270,529 Active US8580319B2 (en) 2009-03-11 2011-10-11 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,021 Active 2031-03-01 US9327004B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,014 Active 2030-05-08 US9233134B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional Chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,035 Active 2031-02-20 US9333231B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional methods of making and using same

Family Applications After (5)

Application Number Title Priority Date Filing Date
US13/270,558 Abandoned US20120270291A1 (en) 2009-03-11 2011-10-11 Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US13/270,529 Active US8580319B2 (en) 2009-03-11 2011-10-11 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,021 Active 2031-03-01 US9327004B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,014 Active 2030-05-08 US9233134B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional Chinese medicinal (TCM) ingredients, and methods of making and using same
US14/043,035 Active 2031-02-20 US9333231B2 (en) 2009-03-11 2013-10-01 Topical compositions comprising fermented extracts of traditional methods of making and using same

Country Status (7)

Country Link
US (6) US20100233301A1 (en)
EP (1) EP2406763A4 (en)
JP (1) JP2012520300A (en)
KR (2) KR20130099247A (en)
CN (1) CN102421413A (en)
SG (1) SG174292A1 (en)
WO (1) WO2010104687A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110238604A1 (en) * 2009-10-05 2011-09-29 Dicanio Denise M Computer-aided diagnostic systems and methods for determining skin compositions based on traditional chinese medicinal (tcm) principles
JP2014500872A (en) * 2010-11-12 2014-01-16 アラーガン、インコーポレイテッド Metabolic conditioned growth medium and methods of use
CN104352423A (en) * 2014-11-23 2015-02-18 沈阳源康医疗器械有限公司 Facial cream containing cordyceps militaris ingredient and preparation method thereof
CN104367543A (en) * 2014-11-27 2015-02-25 沈阳源康医疗器械有限公司 Cream containing cordyceps militaris ingredients and preparation method thereof
CN104367534A (en) * 2014-11-24 2015-02-25 沈阳源康医疗器械有限公司 Essence containing cordyceps militaris ingredients and preparation method thereof
CN104367535A (en) * 2014-11-24 2015-02-25 沈阳源康医疗器械有限公司 Essence containing cordyceps militaris ingredients and preparation method thereof
CN104434764A (en) * 2014-11-25 2015-03-25 沈阳源康医疗器械有限公司 Hydraulic spray containing cordyceps militaris component and preparation method of hydraulic spray
US20150093409A1 (en) * 2009-03-11 2015-04-02 Jing Cheng Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US11547648B2 (en) * 2017-11-15 2023-01-10 L'oreal Composition comprising baicalin and a particular acrylic polymer
US11666518B2 (en) * 2016-08-17 2023-06-06 Natura Cosméticos S.A. Cosmetic anti-blemish composition, use of the composition and method for anti-blemish treatment

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103211723A (en) * 2012-06-26 2013-07-24 广州环亚化妆品科技有限公司 Pudding-shaped cream composition for skin nursing and preparation method thereof
EP2968108B1 (en) 2013-03-14 2020-01-22 Mary Kay, Inc. Cosmetic compositions comprising echinacea purpurea and silybum marianum extracts
US9076551B2 (en) * 2013-03-15 2015-07-07 Nvidia Corporation Multi-phase ground-referenced single-ended signaling
JP2014208596A (en) * 2013-04-16 2014-11-06 一丸ファルコス株式会社 Cosmetics for making horny layer transparent
CN104352424B (en) * 2014-11-24 2017-01-11 沈阳园康天然生物科技有限公司 Cordyceps militaris ingredient containing mask and preparation method thereof
CN104906028B (en) * 2015-06-30 2018-04-27 宋成友 It is a kind of that there is the fermented product composition for improving skin problem and its application
CN105146537B (en) * 2015-08-18 2018-01-09 四川中庸药业有限公司 The preparation method of healthy kitchen medicine materical crude slice
CN105055577A (en) * 2015-09-06 2015-11-18 青海之也科技咨询服务有限公司 Health cordyceps sinensis tablet and preparation method
CN106645534B (en) * 2015-10-30 2018-07-31 湖南康寿制药有限公司 A kind of detection method of 'Shensu ' finger-print
CN108883036B (en) * 2016-03-31 2020-12-08 欧莱雅 Methods and compositions for treating skin conditions
US10231911B2 (en) 2016-03-31 2019-03-19 L'oreal Method and composition for treating skin conditions
US10695278B2 (en) 2016-03-31 2020-06-30 L'oreal Photo-stabilized compositions and methods of use
US11654169B2 (en) * 2016-09-06 2023-05-23 Sinphar Pharmaceutical Co., Ltd. Methods for protecting skin and/or promoting wound healing
EP3369414A1 (en) * 2017-03-01 2018-09-05 The Boots Company PLC Cosmetic skincare compositions
KR101973937B1 (en) 2017-11-30 2019-04-30 아주대학교 산학협력단 Composition comprising fermented extract of Perilla frutescens for preventing, improving or treating sleep disorders
CN108542839A (en) * 2018-04-12 2018-09-18 上海市药材有限公司 A kind of composition of the flower extract containing sarranine and its preparation method and application
JP6973941B2 (en) * 2018-07-05 2021-12-01 株式会社ノエビア Beauty method
JP6377879B1 (en) * 2018-07-05 2018-08-22 株式会社ノエビア Topical skin preparation
JP6391879B1 (en) * 2018-07-05 2018-09-19 株式会社ノエビア Beauty method
CN108992373A (en) * 2018-07-31 2018-12-14 刘经校 Small green mandarin orange facial mask of one kind and preparation method thereof
CN111729012A (en) * 2020-07-22 2020-10-02 桂林医学院 Composition for controlling fat accumulation in fat cells based on active ingredients of dried orange peel
KR102198589B1 (en) * 2020-08-24 2021-01-05 주식회사 아이디플라코스메틱 Whitening cosmetic composition containing Rhodiola rosea, Selaginella tamariscina, Celosia cristata and Artemisia princeps complex extract and phytol
JP7368340B2 (en) 2020-11-13 2023-10-24 金氏高麗人参株式会社 Composition for inhibiting phosphodiesterase 5
CN113456532A (en) * 2021-08-24 2021-10-01 广州莱倩化妆品有限公司 Zero-pore makeup front cream without silicone oil and preparation method thereof
FI20225087A1 (en) * 2022-02-02 2023-08-03 Lumene Oy Use of Nordic plant-based ingredients for supporting a healthy skin microbiome

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677152A (en) * 1984-08-15 1987-06-30 Allied Colloids Limited Polymeric compositions
US4702844A (en) * 1984-08-15 1987-10-27 Allied Colloids Limited Flocculants and their use
US4970252A (en) * 1989-02-15 1990-11-13 Shin-Etsu Chemical Company, Ltd. Oily paste composition
US5236986A (en) * 1991-02-27 1993-08-17 Shin-Etsu Chemical Co., Ltd. Silicone polymers and water-dispersable, pasty silicone oil compositions comprising the same
US5412004A (en) * 1991-11-21 1995-05-02 Kose Corporation Silicone polymer, paste-like silicone composition, and w/o-type cosmetic composition comprising the same
US5654362A (en) * 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5760116A (en) * 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
US5811487A (en) * 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US5837793A (en) * 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5846397A (en) * 1994-08-22 1998-12-08 S. C. Tehman Plant and process for achieving structured waters of the "I" type-inhibitively activated and "S" type stimulatively activated
US6139855A (en) * 1998-03-13 2000-10-31 Color Access, Inc. Structured water in cosmetic compositions
KR20030020908A (en) * 2003-02-24 2003-03-10 이재학 Cosmetic composition using fermentation of natural herb medicine
US20050089499A1 (en) * 2002-01-15 2005-04-28 Philippe Moussou Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
US20060034875A1 (en) * 2002-09-12 2006-02-16 Tetsuo Nakanishi Novel organopolysiloxane polymer, pasty composition, and cosmetic preparation containing the composition
WO2006060475A1 (en) * 2004-12-03 2006-06-08 Nu-Tein Co., Inc. Method for treating skin disorders with xanthophylls
US20060154261A1 (en) * 2005-01-07 2006-07-13 Andrew Saxon Method for determining susceptibility of an individual to allergen induced hypersensitivity
US20060159714A1 (en) * 2003-07-07 2006-07-20 Jean-Noel Thorel Use of an antioxidant in a dermatological and/or cosmetic composition
US20070292409A1 (en) * 2004-06-17 2007-12-20 The Regents Of The University Of California Methods and Compositions for Producing Insulin Sensitization
US20090254572A1 (en) * 2007-01-05 2009-10-08 Redlich Ron M Digital information infrastructure and method
US20100153016A1 (en) * 2008-12-16 2010-06-17 Bruno Stefanon Diagnostic system for selecting nutrition and pharmacological products for animals

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6118708A (en) 1984-07-05 1986-01-27 Pola Chem Ind Inc Makeup cosmetic
RO88054B1 (en) 1984-07-12 2002-06-28 Ioan Manzatu Biologically antagonic acid water, process and installation for producing the same
RO88053B1 (en) 1984-07-12 2002-06-28 Ioan Manzatu Biologically stimulating alkaline water, process and installation for producing the same
FR2754709B1 (en) * 1996-10-23 1999-03-05 Sanofi Sa COSMETIC COMPOSITION CONTAINING AN ANTAGONIST OF GAMMA NEUROPEPTIDE RECEPTORS AND ALPHA 2 ANTAGONISTS THAT MAY BE INCORPORATED IN SUCH A COMPOSITION
CN1185908A (en) * 1996-12-27 1998-07-01 李江 Functional cordyceps sinensis milk, products made from cordyceps sinensis milk and preparation thereof
JP2000072616A (en) * 1998-08-28 2000-03-07 Manda Hakko Kk Humectant for external use
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
JP2001151688A (en) * 1999-11-25 2001-06-05 Ta Stevia Co Ltd Stevia concentration solution agent and ointment for treating dermatosis and method for producing the same
ITNA20000036A1 (en) * 2000-06-02 2001-12-02 Dev Biotechnological Proces Se NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF DANDRUFF.
JP2002212052A (en) * 2001-01-15 2002-07-31 Hajime Ito External preparation
JP2003040793A (en) * 2001-07-24 2003-02-13 Arie:Kk Sheet pack cosmetic, oral capsule and oral tablet
US7651706B2 (en) * 2001-09-13 2010-01-26 Wakunaga Pharmaceutical Co., Ltd. Liquid preparation containing crude-drug extract
JP2003259835A (en) * 2001-12-28 2003-09-16 Oubiken:Kk Production of fermented product and its utilization
JP2003238437A (en) * 2002-02-08 2003-08-27 Ishikawa Tennen Yakko Busshitsu Kenkyu Center Fermented galenical preparation having antioxidative activity
CN1245193C (en) * 2003-05-23 2006-03-15 李森青 Plant leaven with hot and fragrant smell of propylene sulfide and its prepn and use
JP2005179326A (en) * 2003-12-15 2005-07-07 Iona International Corp Cosmetic
JP4585201B2 (en) * 2004-01-23 2010-11-24 丸善製薬株式会社 Androgen receptor binding inhibitor, hair nourishing agent, sebum secretion inhibitor and prostate hypertrophy inhibitor
JP4550480B2 (en) * 2004-04-30 2010-09-22 正 五井野 Composition for scalp and hair
CN1704451A (en) * 2004-06-03 2005-12-07 柏老六 Lutein ointment extracted from marigold and method for extraction thereof
KR20040083388A (en) * 2004-08-09 2004-10-01 김오곤 Method for producing the yellow mud pack of chinese medicine lactic ferments
JP4488861B2 (en) * 2004-10-06 2010-06-23 共栄化学工業株式会社 Cosmetics
JP2006290802A (en) * 2005-04-11 2006-10-26 Kanebo Cosmetics Inc New diagnostic method for constitution and counseling method using the diagnosis
JP2006328014A (en) * 2005-05-30 2006-12-07 Yukihiro Hirose Composition having prevention action on blood flow deterioration
JP2007022936A (en) * 2005-07-13 2007-02-01 Noevir Co Ltd Skin care preparation
JP3830960B1 (en) 2005-08-12 2006-10-11 建仁 河乃 Hair growth substance
KR100721119B1 (en) * 2005-09-14 2007-05-22 주식회사 이엠코리아 Cosmetic composition using effective microorganisms and manufacturing method thereof
JP4771869B2 (en) * 2006-06-07 2011-09-14 小川香料株式会社 Deodorant and deodorant product containing the deodorant
CN1970723A (en) * 2006-12-15 2007-05-30 肖西林 Health-care wine and its preparing process
EP2127646B1 (en) 2007-01-31 2012-08-01 Kaneka Corporation Agent for relief or prevention of xerostomia
KR100742502B1 (en) * 2007-04-12 2007-07-24 이용운 Composition of a traditional oriental medicine for an atopy treatment
KR101456052B1 (en) * 2007-04-20 2014-11-03 주식회사 엘지생활건강 Anti-wrinkle cosmetic composition
KR20080094459A (en) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 Cosmetic composition having antioxidation activity
KR101437939B1 (en) * 2007-04-20 2014-11-03 주식회사 엘지생활건강 Anti-wrinkle cosmetic composition
CN101292949A (en) * 2007-04-27 2008-10-29 欧莱雅 Beauty treatment skin processing method and skin nursing cosmetic product
CN101249156A (en) * 2008-01-09 2008-08-27 赛自金 Proprietary Chinese medicine preparations for curing quasi-molecule laser postoperative acute ophthalmodynia and method of preparing the same
WO2010056229A1 (en) 2008-11-13 2010-05-20 Edward Hall Nutritional supplements and their methods of formulation
US20100233301A1 (en) * 2009-03-11 2010-09-16 Jing Cheng Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same
US8574639B2 (en) 2010-08-17 2013-11-05 ILHWA Co., Ltd. Fermented ginseng concentrate having IH-901
US8986750B2 (en) * 2010-09-17 2015-03-24 Jiangzhong Pharmaceutical Co., Ltd. Use of a traditional chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677152A (en) * 1984-08-15 1987-06-30 Allied Colloids Limited Polymeric compositions
US4702844A (en) * 1984-08-15 1987-10-27 Allied Colloids Limited Flocculants and their use
US4970252A (en) * 1989-02-15 1990-11-13 Shin-Etsu Chemical Company, Ltd. Oily paste composition
US5236986A (en) * 1991-02-27 1993-08-17 Shin-Etsu Chemical Co., Ltd. Silicone polymers and water-dispersable, pasty silicone oil compositions comprising the same
US5412004A (en) * 1991-11-21 1995-05-02 Kose Corporation Silicone polymer, paste-like silicone composition, and w/o-type cosmetic composition comprising the same
US5846397A (en) * 1994-08-22 1998-12-08 S. C. Tehman Plant and process for achieving structured waters of the "I" type-inhibitively activated and "S" type stimulatively activated
US5654362A (en) * 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5837793A (en) * 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5760116A (en) * 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
US5811487A (en) * 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US6139855A (en) * 1998-03-13 2000-10-31 Color Access, Inc. Structured water in cosmetic compositions
US20050089499A1 (en) * 2002-01-15 2005-04-28 Philippe Moussou Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
US20060034875A1 (en) * 2002-09-12 2006-02-16 Tetsuo Nakanishi Novel organopolysiloxane polymer, pasty composition, and cosmetic preparation containing the composition
KR20030020908A (en) * 2003-02-24 2003-03-10 이재학 Cosmetic composition using fermentation of natural herb medicine
US20060159714A1 (en) * 2003-07-07 2006-07-20 Jean-Noel Thorel Use of an antioxidant in a dermatological and/or cosmetic composition
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
US20070292409A1 (en) * 2004-06-17 2007-12-20 The Regents Of The University Of California Methods and Compositions for Producing Insulin Sensitization
WO2006060475A1 (en) * 2004-12-03 2006-06-08 Nu-Tein Co., Inc. Method for treating skin disorders with xanthophylls
US20060154261A1 (en) * 2005-01-07 2006-07-13 Andrew Saxon Method for determining susceptibility of an individual to allergen induced hypersensitivity
US20090254572A1 (en) * 2007-01-05 2009-10-08 Redlich Ron M Digital information infrastructure and method
US20100153016A1 (en) * 2008-12-16 2010-06-17 Bruno Stefanon Diagnostic system for selecting nutrition and pharmacological products for animals

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gu et al. Zhongguo Zhong Yao Za Zhi. 2007 Jun;32(11):1028-1031. abstract only. *
O'Shaughnessy, M. Traditional Chinese Medicine: Esthetician's Guide. Allured Publishing, Jan 1, 2008. 137 pages. *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150093409A1 (en) * 2009-03-11 2015-04-02 Jing Cheng Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same
US9333231B2 (en) 2009-03-11 2016-05-10 Elc Management Llc Topical compositions comprising fermented extracts of traditional methods of making and using same
US9327004B2 (en) 2009-03-11 2016-05-03 Elc Management Llc Topical compositions comprising fermented extracts of traditional chinese medicinal (TCM) ingredients, and methods of making and using same
US9233134B2 (en) * 2009-03-11 2016-01-12 El Management Llc Topical compositions comprising fermented extracts of traditional Chinese medicinal (TCM) ingredients, and methods of making and using same
US8489539B2 (en) * 2009-10-05 2013-07-16 Elc Management, Llc Computer-aided diagnostic systems and methods for determining skin compositions based on traditional chinese medicinal (TCM) principles
US20110238604A1 (en) * 2009-10-05 2011-09-29 Dicanio Denise M Computer-aided diagnostic systems and methods for determining skin compositions based on traditional chinese medicinal (tcm) principles
JP2014500872A (en) * 2010-11-12 2014-01-16 アラーガン、インコーポレイテッド Metabolic conditioned growth medium and methods of use
CN104352423A (en) * 2014-11-23 2015-02-18 沈阳源康医疗器械有限公司 Facial cream containing cordyceps militaris ingredient and preparation method thereof
CN104367535A (en) * 2014-11-24 2015-02-25 沈阳源康医疗器械有限公司 Essence containing cordyceps militaris ingredients and preparation method thereof
CN104367534A (en) * 2014-11-24 2015-02-25 沈阳源康医疗器械有限公司 Essence containing cordyceps militaris ingredients and preparation method thereof
CN104434764A (en) * 2014-11-25 2015-03-25 沈阳源康医疗器械有限公司 Hydraulic spray containing cordyceps militaris component and preparation method of hydraulic spray
CN104367543A (en) * 2014-11-27 2015-02-25 沈阳源康医疗器械有限公司 Cream containing cordyceps militaris ingredients and preparation method thereof
US11666518B2 (en) * 2016-08-17 2023-06-06 Natura Cosméticos S.A. Cosmetic anti-blemish composition, use of the composition and method for anti-blemish treatment
US11547648B2 (en) * 2017-11-15 2023-01-10 L'oreal Composition comprising baicalin and a particular acrylic polymer

Also Published As

Publication number Publication date
US20120328597A1 (en) 2012-12-27
JP2012520300A (en) 2012-09-06
US20150093457A1 (en) 2015-04-02
WO2010104687A3 (en) 2011-01-06
EP2406763A4 (en) 2015-02-11
US9327004B2 (en) 2016-05-03
KR20110132589A (en) 2011-12-08
US8580319B2 (en) 2013-11-12
US20150093409A1 (en) 2015-04-02
US9333231B2 (en) 2016-05-10
CN102421413A (en) 2012-04-18
EP2406763A2 (en) 2012-01-18
WO2010104687A2 (en) 2010-09-16
KR20130099247A (en) 2013-09-05
SG174292A1 (en) 2011-10-28
US20150093461A1 (en) 2015-04-02
US9233134B2 (en) 2016-01-12
US20120270291A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
US9333231B2 (en) Topical compositions comprising fermented extracts of traditional methods of making and using same
US9072717B2 (en) Cosmetic compositions containing alpha glucosidase inhibitors and methods of use
US9387161B2 (en) Method and compositions for reducing pore size, and moisturizing and/or blurring appearance of defects on keratin surfaces
US20090068132A1 (en) Resveratrol Ferulate Compounds, Compositions Containing The Compounds, And Methods Of Using The Same
US20100129305A1 (en) Compositions Containing Extracts From Radish
AU2015217430B2 (en) Method, compositions, and kit for modulating the appearance of volume on keratin surfaces
US9687517B2 (en) Methods and compositions for treating skin
US9125843B2 (en) Methods and compositions for improving the appearance of skin
US9750682B2 (en) Methods and compositions for improving the appearance of skin

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION